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Biocatalysis is nature’s method of transforming organic compounds where enzymes are 
by far the most abundant natural catalyst for this task. Their major advantage lies in their 
selectivity and specificity, be it high chemo‐, regio‐, or enantio-selectivity or specificity. 
Such characteristics have propelled biocatalysis to complement and sometimes replace 
other catalytic routes for synthesizing chemicals, food ingredients, and active 
pharmaceutical ingredients (APIs). Enzymes that require the presence of a flavin cofactor 
for catalysis are called flavoenzymes. In this study, we utilize three different 
flavoenzymes for biocatalysis: mainly nitroreductases (NRs), but also ene-reductases 
(ERs) and NAD(P)H oxdiases (Noxs).  
NRs are enzymes that catalyze the reduction of nitroaromatics to their 
corresponding nitroso, hydroxylamine, and, in limited cases, amine They have gathered 
interest in many scientific communities, and are currently actively researched 
bioremediation and prodrug activation. Here we attempt to utilize them for the purpose of 
synthesizing substituted aromatic amines that are found in a number of active 
pharmaceutical ingredients (APIs). As NRs described in the literature have varying 
product distribution ranges (from those that produce hydroxylamine to others that yield 
amine) several similar and different NRs were studied for their selectivity. Additionally, a 
quantitative structure–activity relationship (QSAR) was determined to characterize the 
substrate specificity of NRs. 
To employ the use of flavoenzymes in synthesis, multiple reaction- and protein-
engineering approaches were devised. One scheme was to establish an enzymo-chemical 
 
 xx
synthesis where NRs were paired with reducing agents for a chemical reduction. Another 
method was to create a monomeric NR through directed evolution from ER scaffolds for 
future immobilization applications. Protein engineering techniques were also utilized on 
NADH oxidases which we characterized and developed for nicotinamide cofactor 
regeneration. As a whole, this dissertation expands our current understanding on NRs and 








Biocatalysis is nature’s method of transforming organic compounds.1 Enzymes are by far 
the most abundant natural catalyst for this task. Their major advantage lies in their 
selectivity and specificity, be it high chemo‐, regio‐, or enantio-selectivity or specificity.2 
Additionally, they have supreme rate enhancement compared to the non-catalyzed 
reaction ( / ) that can range from a 107 to 1019-fold increase.3,4 Enzymatic 
reactions can be conducted at near ambient temperatures and pressures, and are mostly 
run in aqueous medium. This can lead to lower energy costs, and render them 
environmentally benign compared to conventional chemical methods.5 These advantages 
have propelled biocatalysis to complement and sometimes replace other catalytic routes 
in large‐scale applications for synthesizing chemicals, food ingredients, and active 
pharmaceutical ingredients (APIs).6  
 
1.2 Flavoenzymes 
Flavins are yellow colored molecules that have an isoalloxazine ring as a basic structure 
(Figure 1.1). They were first discovered in 1879 from cow’s milk as a bright yellow 
pigment.7 It was initially termed lactochrome (named from where it was discovered), but 
is currently known as riboflavin (vitamin B2) which is the precursor of all other flavins 
occurring in nature. Riboflavin itself is not the common form found in organisms, rather, 
it is found in two modified forms: flavin mononucleotide (FMN) and flavin adenine 
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dinucleotide (FAD) (Figure 1.1). These are mostly found as non-covalently bound 
enzyme cofactors in nature where the protein-ligand interaction primarily depends on the 
ribityl side-chain of the molecule.8 Enzymes that require the presence of either form of 
flavin for catalysis are called flavoenzymes. 
 
 
Figure 1.1 Structure of flavins 
 
 Flavoenzymes are versatile catalysts as they are capable of undergoing one- or 
two-electron transfers. Thus, the flavin can exist either as oxidized, one-electron reduced 
(semiquinone), or two-electron reduced states. As such, they can act as bridges to conjoin 
one- and two-electron redox reactions in biological systems, making them ubiquitous in 
nature.9 Flavoenzyme catalyzed reactions require two-half reactions, where the flavin is 
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initially reduced then subsequently oxidized for complete turnover. Depending on the 
nature of the substrate involved in the reaction, flavoproteins have been divided into five 
major categories.10,11 
A.1 Transhydrogenases – two-electron transfer from one organic molecule to 
another 
A.2 Dehydrogenase-oxidase – molecular oxygen is the oxidizing substrate for 
two-electron transfer 
A.3 Dehydrogenase-monooxygenases – one oxygen atom of O2 is inserted to a 
substrate while the other is reduced to H2O 
A.4 Dehydrogenase-electron transferase – flavin is reduced with two-electrons, 
but is reoxidized with single-electron transfers 
A.5 Electron transferase – one-electron transfer for both reduction and oxidation 
 The enzymes that are discussed in this thesis are transhydrogenases and 
dehydrogenase-oxidases. For detailed reviews of others, the reader is directed towards 
review articles such as “The chemical and biological versatility of riboflavin (Massey, 





Figure 1.2 General mechanism of flavin redox chemistry 
 
 For both transhydrogenases and dehydrogenase-oxidases, the reductive-half 
reaction is a two-electron transfer. The primary electron donors are nicotinamide 
cofactors, namely NADH and NADPH (Figure 1.2). These pyridine nucleotides can 
reduce the flavin through hydride transfer.13 Sequentially, the reduced flavin will in turn 
reduce a substrate. When this is an organic molecule, the enzyme is labeled a 
transhydrogenase, and when it is molecular oxygen the enzyme is termed a oxidase. 
These two types of reactivity are not completely exclusive, as there are 
transhydrogenases that are capable of reducing, at relatively slower rates, O2 as well. In 
this dissertation, three different classes of flavoenzymes are studied: nitroreductases, ene-
reductases and NAD(P)H oxidases. 
 
1.3 Nitroreductases 
Nitroreductases (NRs) are enzymes that catalyze the reduction of nitroaromatics to their 




Figure 1.3 Schematic of two-electron reduction of nitro reduction to amine, with nitroso 
and hydroxylamine intermediates 
 
1.3.1 Literature survey of NR 
Depending on the nature of the first reduction step NRs can be categorized into two 
types. Oxygen-sensitive NRs (type II) catalyze a single electron transfer to produce the 
nitro anionic radical which can subsequently oxidize O2 to produce superoxide radicals. 
There have been a few type II NRs found in Escherichia coli and Clostridium strains.14-16 
Current research on NRs is mostly focused on oxygen-insensitive (type I) NRs that 
perform a two-electron reduction of nitro to form nitroso. Isolated and characterized NRs 
include NfsA and NfsB from E. coli 17,18, NR from Enterobacter cloacae 19, NRSal (or 
Cnr) from Salmonella typhimurium 20, SnrA from Salmonella typhimurium 21, 
nitrobenzene nitroreductase (nbzA) from Pseudomonas pseudoalcaligenes 22, 
NAD(P)H:FMN oxidoreductase (FRase I) in Vibrio fischeri 18,23, RdxA from 
Helicobacter pylori 24, nbzA from Pseudomonas putida 25, PnrA and PnrB from 
Pseudomonas putida JLR11 26, NitA and NitB from Clostridium acetobutylicum 27, 
GlNR1 (Fd-NR2) from Giardia lamblia 28, NfnB from Mycobacterium smegmatis 29, 
TbNTR from Trypansoma brucei 30, Ssap-NtrB from Staphylococcus saprophyticus 31, 
Frm2 from Saccharomyces cerevisiae 32, NR from Streptomyces mirabilis 33, MsAcg 
from Mycobacterium smegmatis 34, TcNr from Taiwanofungus camphorates 35, LmNTR 
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from Leishmania major 36, BaNTR1 from Bacillus amyloliquefaciens 37, and many 
others. 
 Type I NRs have previously been classified into two main groups, where the 
designation is based upon the different NRs that were identified in E. coli by Bryant et 
al.38 NfsA (group A) is the major NR that uses exclusively NADPH as the electron donor, 
and NfsB (group B) is the minor NR that can use both NADH and NADPH for 
reduction.17,18 However, the expansion in the family now makes it difficult to categorize 
all NRs in to these two groups. 
As there are a vast number of NRs studied throughout the community, in this 
thesis we focus on the NfsB type NRs, namely NRsalty from S. typhimurium 20,39, 
NRentcl from E. cloacae 19,40 and NRmycsm from M. smegmatis 29 (futher explanation as 
to why these enzymes were selected are in Section 2.1, and discussion regarding the 
nomenclature is provided in Appendix A).  
 
 
Figure 1.4 Crystal structure of NRentcl (left; PDB ID: IKQB) and NRmycsm (right; 




The crystal structure of NRentcl and NRmycsm have previously been solved 
(there is none for NRsalty), and both have shown to be homodimeric enzymes with a 
flavin mononucleotide (FMN) prosthetic group for catalysis (Figure 1.4).29,42 The FMN 
cofactor is non-covalently bound at the dimer interface, where there are two symmetric, 
but independent, active sites constructed with residues from both monomeric subunits. 
These structures are very similar to that of NfsB from E.coli 43,44, NADH oxidase in 
Thermus thermophilus 45, flavin reductase P (FRP) in Vibrio harveyi 46, FRase I from 
Vibrio fischeri 47. As discussed previously, these enzymes do not prefer one nicotinamide 
cofactor over the other. This is mainly because there is no binding domain, such as the 
Rossmann fold, for NAD(P)H backbone interaction. 
Overall the NRs undergo a bi-bi ping-pong mechanism, where both the reduced 
nicotinamide co-substrate and substrate take turns binding at the re face of the flavin.40,42 
However, despite the many mutational 48-52 and computational studies 53 conducted on 
NRs, there are still many unknown details regarding the mechanism. The presence of any 
catalytically active residues has yet to be identified, and the mechanism of nitro reduction 
has yet to be elucidated. These are some of the questions that are partially addressed in 
this thesis. 
Additionally, other than the enzymes discussed above, there are some that can 
reduce non-aromatic nitro groups. The substrates can be xenobiotic nitro esters such as 
glycerol trinitrate (GTN) and pentaerythritol tetranitrate (PETN), or nitro alkenes that are 
conjugated with an aromatic ring such as nitro styrenes as substrates. The well-known 
ones include glycerol trinitrate reductase (NerA) from Agrobacterium radiobacter 54 and 
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pentaerythritol tetranitrate (PETN) reductase from Enterobacter cloacae 55. Both are 
members of the old yellow enzyme (OYE) family, and will be discussed in Section 1.4.1. 
1.3.2 NR applications 
NRs have gathered interest in many scientific communities, and currently there are two 
major active fields where they are being studied. 
 
 
Figure 1.5 a) Bioremediation of trinitrotoluene (TNT) to triaminotoluene (TAT). 
b) Prodrug (CB1954) activation in vivo to create a DNA crosslinking agent 
 
The first is for bioremediation where possible degradation of xenobiotic nitroaromatics, 
such as trinitrotoluene (TNT) and picric acid, has received the most attention (Figure 
1.5a). Nitroaromatic compounds are used to synthesize dyes and explosives and can be 
produced by nitration and incomplete combustion of fossil fuels.56 The anthropogenic 
nature of these compounds makes it difficult for nature to degrade. Also, the presence of 
an uncontrolled reduction can possibly yield a nitroso and/or hydroxylamine compound, 
which is more toxic than the original compound.56,57 Microorganisms that degrade 



























Mycobacterium 59, Rhodobacter capsulatus 60, Escherichia coli 61,62, Saccharomyces sp. 
ZS-A1 63, Candida sp. AN-L14 63, Klebsiella sp. 64, Pseudomonas aeruginosa 65, 
Pseudomonas putida KP-T202 66, Irpex lacteus 67, Yarrowia lipolytica 68, Cellulomonas 
sp. ES6 69, Fusarium oxysporum 70, and Raoultella terrigena HB 71. However, the 
specific enzymes responsible for the multiple reactions involved in the reduction of these 
xenobiotics often have yet to be characterized and understood completely.  
The second is the coupled use of NRs with prodrugs to activate them for medical 
applications, namely antibody-directed enzyme prodrug therapy (ADEPT) 72-74, gene-
directed enzyme pro-drug therapy (GDEPT) 75-77 and virus-directed enzyme pro-drug 
therapy (VDEPT)78,79. In these therapies, the enzymes with specific functions of interest 
are delivered to the medication site and coupled with a prodrug. This prodrug that 
originally is inactive when first delivered will become activated through the enzyme to 
complete its medicinal purpose (Figure 1.5b). A procedure with NRs will involve the 
enzyme to activate a prodrug by reducing aromatic nitro groups to hydroxylamines which 
will then crosslink to DNA and cause cell death. Such applications are envisioned for the 
treatment of cancer. 
Further, in this study, the application of NRs will be investigated for active 
pharmaceutical ingredient (API) syntheses which involve the reduction of aromatic nitro 
groups to amines. Substituted aromatic amines can be found in a number of API 
syntheses as intermediates or final products. Some examples include sildenafil, the 





Figure 1.6 Active pharmaceutical ingredients (APIs) with aromatic amine production 




Figure 1.7 Proposed reduction pathways of nitrobenzene to aniline through i) the direct 
route and ii) condensation route by Fritz Haber.81 Figure adapted and modified from 




1.3.3 Nitrobenzene reduction and state of the art 
The nature of nitrobenzene reduction is complex compared to the simple one-step 
reaction typically depicted in organic chemistry text books.83,84 The difficulties are well 
documented: Fritz Haber demonstrated the formation of several intermediates and side-
products on electrode surfaces as early as 1898 (Figure 1.7).81,85 Most notably, nitroso- 
and hydroxylamines were formed as intermediates from the direct pathway of producing 
amines, while the condensation pathway of intermediates yielded azoxy-, azo-, and 
hydrazobenzene as side-products. 
Conventional organic syntheses for aromatic amines involve catalytic 
hydrogenation of nitro precursors with hydrogen gas and noble metal catalysts such as 
palladium, platinum and rhodium.86 Two main aspects, namely chemoselectivity and 
sustainability, are currently being addressed for further improvement of these 
technologies. The traditional methods are very effective for nitro reduction, but 
frequently lack chemoselectivity and catalyze additional side-reactions.82,87,88 In 
particular, catalytic hydrogenation can lead to the reduction of functional groups such as 
carbonyls and unsaturated carbon bonds 88,89 or dehalogenation of substituted 
nitroaromatics, i.e. the release of HCl, HBr or HI.90,91 Such limitations have been 
overcome to some extent through catalyst modification by alloying or poisoning with 
metal oxides. Although these alterations have shown to improve selectivity they also lead 
to a decrease in activity.92 Transfer hydrogenation is seen as an attractive alternative that 
also exhibits better selectivity. This method is considered advantageous as it utilizes 
reducing agents such as sodium dithionite, iron, tin, or zinc in ammonium chloride or 
ammonium formate instead of hydrogen gas.92-94 Literature examples include the use of 
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rhodium, palladium, ruthenium, copper and cobalt complexes as catalysts.89,95-98 However, 
the use of precious metals in both techniques has raised concern due to their scarcity and 
high costs.99 For improved sustainability, recent advances in the heterogeneous catalysis 
field have focused on utilizing abundant materials such as iron and nickel. Examples 
include the use of Fe2O3- based particles in water-THF 98, Fe(BF4)2·6H2O with mono- 
and bidentate phosphines 93, and silica gel supported Ni-catalysts 99.  
Overall, there have been significant advances not only to address the selective 
production of amine from nitro precursors but also to limit side-reactions occurring on 
additional substituents. Further, many technologies have been developed to address the 
sustainability of heterogeneous catalytic methods by avoiding the use of metals as 
catalysts. However, the use of these technologies is still less than straight forward when 
utilizing these procedures on complex molecules, such as those found in the 
pharmaceutical industry. High-throughput systems have been developed to find optimal 
conditions for each target molecule and these studies have confirmed that these 
conditions can differ drastically from molecule to molecule.80 
Biocatalytic reduction of nitro arenes is considered as an alternative pathway for 
the production of amines in relatively mild conditions which will be favorable in terms of 
energy costs. Further, the use of an enzymatic route is touted for the use in latter stages of 
a synthesis where the presence of multiple functional groups will require the use of an 
extremely chemoselective catalyst. Moreover, the Food and Drug Administration (FDA) 
has strict regulations against heavy metal contamination in pharmaceuticals.100,101 
Therefore, an approach centered on a biocatalytic route is sought for the reduction of 




1.4 Other flavoenzymes 
The main enzyme of interest is the NR in this dissertation. However, there are additional 
projects that involve the use of flavoenzymes that are introduced here. 
1.4.1 Ene-reductases 
Ene-reductases (ERs), or enoate reductases, are enzymes capable of reducing ,  
unsaturated carbon-carbon double bonds with adjacent electron-withdrawing groups such 
as aldehydes, ketones, carboxylic acids, esters, nitriles, and nitro groups (Figure 
1.8).102,103 Their biggest utility lies in their ability to create up to two chiral centers while 
reducing an alkene substrate.  
 
 
Figure 1.8 Schematic of asymmetric reduction of alkenes with adjacent electron-
withdrawing groups (EWG) 
 
 The old yellow enzyme (OYE) family is well known class of flavoenzymes that 
can reduce activated C=C bonds at the expense of nicotinamide cofactors. Enzymes in 
this family include OYE1 from Saccharomyces pastoris 104,105, OYE2 and OYE3 from 
Saccharomyces cerevisiae 106,107, morphinone reductase (MR) from Pseudomonas putida 
108, pentaerythritol tetranitrate (PETN) reductase from Enterobacter cloacae 55, N-
ethylmaleimide reductase (NemA) from Escherichia coli 109, glycerol trinitrate reductase 
(NerA) from Agrobacterium radiobacter 54, xenobiotic reductase A (XenA) from 
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Pseudomonas putida 110, xenobiotic reductase B (XenB) from Pseudomonas fluorescens 
110, TcOYE from Trypanosoma cruzi 111, 12-oxophytodienoate reductases (OPR1-3) from 
Arabidopsis thaliana and Lycopersicon esculentum 112,113, YqjM from Bacillus subtilis 114, 
SYE1-4 from Shewanella oneidensis 115, KYE1 from Kluyveromyces lactis 116, YersER 
from Yersinia bercovieri 116, NCR from Zymomonas mobilis 117, TOYE from 
Thermoanaerobacter pseudethanolicus E39 118, and others. There have been suggestions 
that OYEs are implicated in the antioxidant defense system, but their physiological role 
has yet to be determined.103,114,119 
 
Figure 1.9 Crystal structure of OYE1 from Saccromyces pastoris (PDB ID: 1OYB) 
colored according to secondary structure; α-helices (orange) and β-sheets (blue). Image 
rendered with VMD.41 
 
 OYEs have a TIM barrel fold, also known as a (αβ)8 fold, which is derived from 
the name of triosephosphate isomerase (TIM), the first enzyme crystallized with such a 
structure.120 Eight α-helices and parallel β-sheets alternate to form a central barrel 
comprised of β-strands, which is surrounded by an outer barrel of α-helices. The active 
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site is located at the C-terminal end of the β-barrel, where the FMN cofactor is bound 
(Figure 1.9). 
 Similar to NRs, substrate reduction happens through a bi-bi-ping-pong 
mechanism.121 ERs from the OYE family, in most cases, prefer NADPH as the electron 
source. The hydride of the NADPH is transferred to the N5 position of the flavin to be 
reduced in the reductive half-reaction. Subsequently, in the oxidative half-reaction, the 
hydride is transferred to the β-carbon and is followed by a proton addition to the α-
carbon. Compared to the catalytic hydrogenation methods which commonly undergo a 
syn-addition, biocatalytic ones undergo an anti-addition of hydrogens.122-124 Considering 
OYE1 as an example, His-191 and Asn-194 (which can be His in some OYEs) are known 
to be important for substrate binding as they hydrogen bond with the carbonyl oxygen.125 
Tyr-196 has been shown to be the proton donor, but can be replaced with water as 
well.126 
1.4.2 NAD(P)H oxidases 
NAD(P)H oxidases (Noxs) are enzymes that catalyze the oxidation of NAD(P)H to 
NAD(P)+, while reducing molecular oxygen. They can be divided into two groups 
depending on the extent of O2 reduction. nox1 NAD(P)H oxidases are ones that catalyze 
a two-electron transfer to produce hydrogen peroxide, while nox2 catalyzes a four-
electron transfer to yield water (Figure 1.10).127,128 As H2O2 can deactivate enzymes, 
water producing nox2 have more potential to be useful in the context of biocatalysis. 






Figure 1.10 Schematic of molecular oxygen reduction with either two-electron (nox1) or 
four-electron (nox2) reduction 
 
 
Figure 1.11 Crystal structure of NADPH oxidase from Lactobacillus sanfranciscensis 
(PDB ID: 2CDU) colored by subunit and ligands; FAD (yellow) and adenosine 
diphosphate (ADP; blue). The ADP binding site is where NAD(P)H will potentially bind 
for catalysis. Image rendered with VMD.41 
 
Water-forming Noxs have been shown to be active as homodimers where each 
monomer has a bound flavin adenine dinucleotide (FAD) cofactor.129,130 Known nox2 
enzymes include ones from Streptococcus mutans 131, Enterococcus faecalis 132, 
Lactobacillus sanfranciscensis 128, Lactobacillus brevis 133, Lactococcus lactis 134. The 
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structure is a Rossmann fold, which is common for enzymes that take NAD(P)H as a 
substrate.135 All previously discovered nox2 NAD(P)H oxidases have a conserved 
cysteine residue that is catalytically active.133,134,136,137 This is supported by the fact that a 
Nox with a cysteine mutated to serine produced H2O2 instead of water.138-140 During 
catalysis, the thiol (–SH) or thiolate (–S–) is oxidized to sulfenic acid (–SOH) and 
reduced back to the thiol/ate as a part of the NAD(P)H reduction mechanism (Figure 
1.12).130 During this redox cycle the cysteine can also be overoxidized, producing a 
sulfinic (–SO2H) and then a sulfonic acid (–SO3H), irreversibly, and thereby deactivating 
the enzyme.141,142 This is the presumed cause of turnover-limited operational stability of 
nox2 proteins.139,143 Overoxidation of this cysteine residue can be decelerated by 
employing exogenous reducing agents such as dithiothreitol (DTT) or -mercaptoethanol 
(BME)143; thus, extending the useful active enzyme lifetime and its total turnover number 
(TTN), a measure of operational stability. 
 
 
Figure 1.12 Overall Reactions Catalyzed by nox2 NAD(P)H Oxidases. Scheme is 




1.5 NAD(P)H regeneration 
As noted previously, oxidoreductases such as NRs and ERs consume NAD(P)H as 
coenzymes. However, high costs make it difficult to use them in stoichiometric quantities 
(Table 1.1). Therefore, an in situ regeneration system needs to be implemented for 
sustainability. Several methods have been investigated including chemical, 
electrochemical, photochemical, and enzymatic approaches (for detailed reviews on these 
methods see “Regeneration of Nicotinamide Coenzymes: Principles and Applications for 
the Synthesis of Chiral Compounds (Weckbecker et al. 2010)”.144,145 Among these, the 
enzymatic method is known to have the highest selectivity and total turnover number 
(TTN; the moles of product produced by each mole of catalyst over its lifetime).146 
 
Table 1.1 Cost of nicotinamide cofactors 147 and regeneration systems148 








 There are several enzymes that are useful for reduction of oxidized nicotinamide 
cofactors. These include the enzymes formate dehydrogenase (FDH) 149-151, glucose 
dehydrogenase (GDH) 152,153, glucose-6-phosphate dehydrogenase (G6PDH) 154,155, 
alcohol dehydrogenase (ADH) 156-159 and phosphite dehydrogenase (PTDH) 160,161 (Figure 
1.13). Among these, GDH will be used in this thesis to establish the NAD(P)H recycling 





Figure 1.13 NAD(P)H regeneration scheme with different enzymes. 
 
1.6 Map of Dissertation 
This thesis studies various applications of flavoenzymes for organic synthesis. Chapter 2 
discusses the reduction of nitrobenzene with NRs and the product distribution. Chapter 3 
investigates the substrate specificity of NRs and characterizes the reactivity in relation to 
the substrate structure. Chapter 4 employs NRs in conjunction with reducing agents, 
namely formamidine sulfinic acid (FSA) for the enzymo-chemical synthesis of aromatic 
amines. Chapter 5 is a study that utilizes protein engineering to create a NR from a 
monomeric ER scaffold. Chapter 6 characterizes of an NADH oxidase for a stable 
cofactor regeneration system. Chapter 7 summarizes the main findings in each chapter 
























2REDUCTION OF NITROBENZENE WITH NITROREDUCTASES 
 
2.1 Introduction & Motivation 
Nitroreductases (NRs) have been identified and partially characterized for its 
nitrobenzene reduction pathway. The product distribution of NRs described in the 
literature can be categorized into two groups based upon the extent of reduction. In 
extensively studied NRs, including those from E. coli (NRescco) and Enterobacter 
cloacae (NRentcl), it is reported that the hydroxylamine is produced as the major product 
from nitroaromatics.40,162 More recently, Yanto et al. studied NRsal (NRsalty in this 
article) from Salmonella typhimurium, showing a 6% yield of aniline from nitrobenzene 
reduction. Other side-products included the intermediates nitroso and hydroxylamine in 
small quantities along with the condensation product of the nitroso and hydroxylamine 
states, azoxybenzene at a 70% yield.39 Another example of an NR producing an amine 
was found in NRmycsm from Mycobacterium smegmatis, where Manina et al. were able 
to reduce the antituberculosis drug BTZ043 to the corresponding amine, BTZ045, 
however, with unknown yield and volumetric productivity.29 
 This difference in product distribution becomes more intriguing when considering 
the high amino acid similarity that NRsalty has compared to NRescco and NRentcl 
(Table 2.1). To investigate the reason for this variance the reported reaction conditions 
for NRsalty and NRentcl were investigated and compared to see if this dictated the final 
reduction state. Additionally, NfnB from M. smegmatis (NRmycsm), which is very 
different in sequence homology and produces the amine, was included in these studies to 




Table 2.1 Comparison of amino-acid sequence identity/similarity. Uniprot accession 
numbers: NRsalty (P15888), NRentcl (Q01234), NRescco (P38489), NRmycsm 
(A0R6D0) 
% NRsalty NRentcl NRescco NRmycsm 
NRsalty - 89/92 89/91 6/15 
NRentcl 89/92 - 88/90 6/13 
NRescco 89/91 88/90 - 6/13 
NRmycsm 6/15 6/13 6/13 - 
 
2.2 Materials & Methods 
2.2.1 Enzymes and other materials 
The gene of nrentcl from E. cloacae was a kind gift from Dr. Anne-Frances Miller 
(University of Kentucky). nrmycsm from Mycobacterium smegmatis was a generous gift 
from Dr. Giovanna Riccardi at the Università degli Studi di Pavia. NADH and NADPH 
were obtained from Amresco (Solon, OH) and EMD chemicals (Gibbstown, NJ), 
respectively. Phenylhydroxylamine was a kind gift from Dr. Jim Spain (Georgia Tech). 
Other hydroxylamines were synthesized according to Section 2.2.9. Nitrobenzene 
(unlabeled and 15N-labeled), nitrosobenzene, aniline (unlabeled and 15N-labeled), 
azoxybenzene, deuterated solvents (acetonitrile-d3), and other general chemicals were 
purchased from Sigma-Aldrich (St. Louis, MO). 
2.2.2 Protein Expression 
The genes nrsalty and nrmycsm were expressed in pET-28a vectors, and nrentcl was 
expressed in pET-32a with a thioredoxin (TRX)-tag for increased solubility of the protein 
(for additional construct information see Appendix C). Plasmids were transformed into 
BL21(DE3) cells for expression. 1 L cultures were inoculated using 1% (v/v) overnight 
precultures with appropriate antibiotics (30 µg.mL-1 of kanamycin for pET-28a, and 50 
µg.mL-1 of ampicillin for pET-32a), and grown at 37 °C. When OD600 reached 0.5~0.7 
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protein expression was induced with 1 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG). After induction, cultures of NRsalty and NRentcl-TRX were expressed at 37 °C 
for 8 h and 4 h, respectively, and NRmycsm was expressed overnight (~16 h) at 28 °C. 
Cells were harvested with a Beckman floor centrifuge at 4050 g for 10 min. Pellets were 
either directly used for purification or stored at -80 °C. 
2.2.3 Purification of Enzymes 
Purification was performed at 4 °C or on an ice bath, and centrifugation steps were 
carried out with a Sorvall RC5Bplus centrifuge at 26940 g for 30 min. NRsalty was 
purified according to a previous study with modifications.39 Cell pellets were 
resuspended in 20 mL of 50 mM Tris-Cl pH 7.5 (buffer A) and sonicated at 14 W for 30 s 
nine times with 30 s breaks in between. Lysed cells were centrifuged, and saturated 
ammonium sulfate solution was added to the clarified lysate to a final concentration of 
40%. The sample was equilibrated with constant mixing for an hour and then centrifuged. 
Additional saturated ammonium sulfate solution was added to the supernatant to a final 
concentration of 70%. After one hour of equilibration the sample was centrifuged, and 
the pellet was resuspended with 5 mL of buffer A. Next, the sample was dialyzed against 
500 mL of buffer A for 2 h and then transferred into fresh buffer and further dialyzed for 
another 2 h. The protein was filtered through 0.8 and 0.2 µm membrane microfilters in 
series. Filtered protein solution was injected on to an ÄKTAexplorer™ (GE Healthcare 
Life Sciences; Piscataway, NJ) equipped with a HiPrep 16/10 DEAE anionic exchange 
column, pre-equilibrated with buffer A. Gradient separation was performed from 10 to 
30% using buffer A with 1 M NaCl (buffer B) over 15 column volumes (CVs). Fractions 
were collected, assayed for activity, and concentrated to less than 2 mL with 3 kDa 
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molecular weight cutoff (MWCO) Nanosep® centrifugal devices (Pall; Port Washington, 
NY). FMN was exogenously added to a final concentration of 0.2 mM and incubated for 
1 h. The FMN supplemented enzyme solution was injected on a HiPrep 16/60 Sephacryl 
S-300 column and eluted with an isocratic flow of buffer A with 150 mM NaCl.  
 Purification of NRmycsm and NRentcl-TRX was carried out with standard his-tag 
affinity chromatography. Cell pellets were resuspended in 20 mL of 50 mM sodium 
phosphate, 300 mM NaCl, and 20 mM imidazole at pH 8.0. Cell slurry was sonicated at 
14 W for 30 s nine times with 30 s breaks in between. Lysed cells were centrifuged, and 
the resulting supernatant was incubated with exogenous FMN with a final concentration 
of 0.2 mM for 1 h. The sample was bound to 2 mL of Ni-NTA resin with gentle rocking 
at 4 °C for 45 min, and then purified with column chromatography. The resin was washed 
with five column volumes (CVs) of 50 mM sodium phosphate (pH 8.0), 300 mM NaCl, 
and 50 mM imidazole two times. Afterwards, the protein was eluted with 0.5 CVs of 50 
mM sodium phosphate (pH 8.0), 300 mM NaCl and 250 mM imidazole eight times.  
 Active fractions were determined and stored at -20 °C with 50% (v/v) glycerol. 
Protein concentration was determined through the Bradford assay 163, and purity was 
analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE).  
 FMN occupancy was determined according to the method published by Chapman 
and Reid.164 A 5 to 10 M enzyme solution was heated for 10 min at 90 °C. The 
precipitated protein was centrifuged for 10 min at 13000 rpm. The absorbance spectra of 
liberated FMN in the supernatant were scanned, and the concentration was determined 
with an extinction coefficient at 446 nm, , of 12,200 M-1.cm-1. 
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2.2.4 Enzyme Assays 
Spectrophotometric studies were performed on a Beckman Coulter DU 800 UV/Vis 
spectrophotometer (Pasadena, CA). Spectral scans of substrates were taken at a 
concentration of 100 M from a range of 200 to 800 nm. When studying the effect of 
oxygen, anaerobicity was achieved by bubbling buffer with nitrogen gas and preparing 
samples in a glove bag (Glas-Col; Terre Haute, IN) also purged with nitrogen.  
Nitrobenzene reduction was performed with 100 M nitrobenzene, 5 U.mL-1 
glucose dehydrogenase (GDH), 10 M NAD+, 10 mM dextrose, and 1 M NR in 100 
mM PIPES buffer with 50 mM KCl (pH 7.0). The change in wavelength absorbencies 
was monitored for 90 min, with an interval of 10 min. Additional conversion assays for 
product identification were carried out with identical conditions with the exception of 
using 50 mM Tris-Cl (pH 7.5) instead of a PIPES buffer at a 1 mL scale. The products 
were extracted with 0.5 mL of ethyl acetate and either analyzed on GC or further dried 
over a gentle stream of argon gas, and resuspended in water:acetonitrile (50:50) for 
HPLC and LC-MS analysis. 
2.2.5 Gas chromatography (GC) 
GC-FID analysis was performed on a Shimadzu GC-2010 with a Shimadzu SHRX5 
column (15 m, 0.25 mm, 0.25 m). Temperature program: injector and detector 
temperature at 300 °C; split ratio 25:1; start at 80 °C, hold 5 min, 10 °C.min-1 to 290  °C, 
hold 5 min. Retention time: nitrosobenzene 1.4, aniline 2.0 min, min, nitrobenzene 3.5 






Enzymatic reduction of 15N-labeled nitrobenzene was scaled up to 200 mL. The reaction 
was carried out with conditions identical to the spectrophotometric assays, with the 
exception of using 50 mM Tris-Cl (pH 7.5) as the buffer. The reaction was continued for 
6 h, and the product was extracted with ethyl acetate three times (100, 50, and 20 mL). 
The extract was dried with anhydrous magnesium sulfate (MgSO4), filtered, and 
concentrated to 1 mL through rotary evaporation. The reaction product was dissolved in 
acetonitrile-d3, for NMR. 15N-NMR spectra was recorded on a Bruker Avance III HD-
500 at 50.70 MHz using inverse gated proton decoupling, with the assistance of Dr. 
Gelbaum from the Georgia Tech NMR center.  
2.2.7 High-performance liquid chromatography (HPLC) analysis 
Analysis was conducted with a Shimadzu LC-20AT pump (Kyoto, Japan), Phenomenex 
Luna® 5 µM C18 100 Å 250 x 4.6 mm (Torrance, California), and SPD-M20A 
prominence diode array detector (PDA). Separation was achieved with an isocratic flow 
of acetonitrile and water. Flow compositions and detection wavelengths are summarized 
in Table 2.2. Samples were prepared by diluting with acetonitrile and centrifuging for 5 
min before sampling.  
2.2.8 Liquid chomatography-mass spectroscopy (LC-MS) analysis 
Analysis was performed with an Agilent 6320 Ion Trap LC-MS system (Santa Clara, CA) 
with Electrospray Ionization (ESI). Separation was achieved on an Agilent ZORBAX 
SB-C18 5 μM 150 x 0.5 mm capillary HPLC column with an isocratic flow of 




2.2.9 Synthesis of hydroxylamino compounds 
Hydroxylamine standards 4-(hydroxyamino)benzoic acid and 4-(hydroxyamino)benzene 
sulfonamide were synthesized from their parent nitro compounds according to previously 
published methods by Bauer et al.165 1-Nitroso-3-(trifluoromethyl)benzene was oxidized 
from 3-aminobenzotrifluoride using m-chloroperoxybenzoic acid according to previously 
published methods.166,167 N-Hydroxy-3-(trifluoromethyl)-benzenamine was obtained from 
reduction of the nitroso derivative with ascorbic acid.166,168 
 
2.3 Results & Discussion 
2.3.1 Expression and purification of NRs 
NRsalty purification was modified for a larger-scale production. Size-exclusion 
chromatography (SEC) was added as a last step to eliminate impurities. Both NRentcl-
TRX and NRmycsm were purified with a His-tag Ni-NTA system. For nrmycsm, in 
addition to the N-terminal his-tag, the stop codon was eliminated to add a his-tag at the 
C-terminus (performed by the Riccardi group), to facilitate purification. This may help 
achieve that goal, but the effect towards the enzyme activity or stability is unknown. 
NRmycsm was found to express better at lower temperature (~28 °C) than the traditional 
37 °C. As the earlier elutions contained slight impurities, experiments were carried out 
with the latter fractions (Figure 2.1). 
 All three NRs utilize FMN as a cofactor. As the cofactor is essential for catalysis, 
the occupancy (ratio of FMN/enzyme) was determined by denaturing the enzyme, 
eliminating the aggregated protein, and measuring the absorbance spectrum of free FMN. 




Figure 2.1 SDS-PAGE with 12% gel of a) NRsalty (left) and b) NRmycsm (right) to 
confirm protein purity. Lysate: clarified lysate; (NH4)2SO4 70%: supernatant from 
centrifuged sample with 70% ammonium sulfate; (NH4)2SO4 dia.: ammonium sulfate 
precipitated protein pellet resuspended and dialyzed against 50 mM Tris-Cl (pH 7.5); 
DEAE pooled: fractions collected from HiPrep 16/10 DEAE column; DEAE conc.: 
combined DEAE sample concentrated with Nanosep® centrifugal devices; SEC frac. 1-3: 
fractions collected from HiPrep 16/60 S-300 column; Non-bound: cell lysate that did not 
bind to Ni-NTA; Elution 2-6: fractions eluted from Ni-NTA column. 
 
 






















Figure 2.3 Spectral studies of nitrobenzene and its derivatives; (a) spectral 
characterization of standards at 0.1 mM; (b) instability of PHA; oxidation of PHA in (c) 
aerobic and (d) anaerobic conditions. 
 
2.3.2 Spectral Characterization 
Spectral characteristics of nitrobenzene and its reduced states were recorded and 
compared (Figure 2.3a). Although it is difficult to differentiate phenylhydroxylamine 
(PHA) and aniline (AN), nitrobenzene (NB) and nitrosobenzene (NOB) were easily 
discernible from both with a λmax of 268 and 310 nm, respectively. When measuring the 
spectrum of PHA, it was found to be unstable, and to change rapidly over time. By 
observing the resulting spectrum, it was suspected that the PHA was converting to NOB 




































































































(Figure 2.3b, c). This hypothesis was supported with literature examples that PHA could 
oxidize to NOB in the presence of molecular oxygen.169,170  An attempt to create a PHA 
solution anaerobically was made by purging the buffer with N2 before adding the 
substrate inside an anaerobic glove bag, also purged with nitrogen gas. The stability of 
PHA was monitored spectrophotometrically, and was shown to be stable over the course 
of an hour (Figure 2.3d). Further experiments were performed in the presence and 
absence of O2, where azoxybenzene was formed in aerobic conditions (data not shown). 
2.3.3 Study of NRsalty and NRentcl-TRX 
The reduction of NB with NRentcl-TRX was performed as previously reported and the 
product formation was compared to that of NRsalty40. For both enzymes, the 
characteristic peak of NOB at 310 nm was undetectable as an intermediate on the 
spectrophotometer. The absence of a NOB signal indicates that the first reduction step is 
rate-limiting, and the subsequent reduction from NOB to PHA happens instantaneously.40  
Further, this second reduction step can occur solely with the cofactor NAD(P)H, but the 
presence of NR increases the rate of reaction, confirming that NOB is a substrate for NRs 
(data not shown). As previously reported reaction conditions varied (e.g. buffer salts and 
additives), the reduction was repeated while varying the reaction components to see if the 
selectivity was affected. However, no discernible difference was observed on the 
spectrophotometer, and the reason for nitrosobenzene detection from NRsalty39 was 
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unclear from these experiments. As the characteristic absorbencies were similar for PHA 
and AN, it was determined that a spectrophotometric assay alone was insufficient to draw 
a conclusion on the final redox state, necessitating an alternative analytical tool for 
product analysis.  
 
Figure 2.4 Nitrobenzene reduction monitored on the spectrophotometer, catalyzed by a) 
NRentcl and b) NRsalty with 100 M nitrobenzene, 5 U.mL-1 glucose dehydrogenase 
(GDH), 10 M NAD+, 10 mM dextrose, and 1 M NR in 100 mM PIPES buffer with 50 
mM KCl (pH 7.0) at 25 °C 
 
2.3.4 Product characterization through multiple analytical tools 
To overcome the shortcomings of the spectrophotometer assay, gas chromatography with 
a flame ionization detector (GC-FID) was selected to separate and detect PHA and AN. 
However, this method was found to be problematic for PHA. When analyzing PHA 
standards, the chromatograms showed significant amounts of NOB and AN, as well as 
AYB. Due to the uncertainty of whether the sample or analytical tool was the cause for 
such a phenomenon, an attempt was made to avoid using PHA as the starting substrate. 







































and an NADH recycling system was implemented with the premise that NADH alone 
will be able to reduce the NOB to PHA and provide a clean substrate to start with. 
Surprisingly, all runs, including the negative control with no NR, showed similar levels 
of amine formation. Such observations lead to the hypothesis that the analytical tool, 
rather than the substrate, was causing the false positive signal of amine. This thought is 
further supported by the fact that hydroxylamines are known to be unstable in the 
presence of oxygen and at elevated temperatures.170,171 It is speculated that during 
injection two molecules of hydroxylamine will undergo disproportionation to form NOB 
and AN as the oxidized and reduced product. To confirm the hypothesis that aniline was 
being formed through the GC instrument alternative analytical tools such as HPLC, LC-
MS and NMR were selected to characterize the product distribution. 
15N-NMR was initially considered as a method to monitor the reaction in real-
time. However, this proved to be non-trivial due to low substrate solubility and slow 
signal acquisition times. Alternatively, an enzymatic reduction of NB was performed 
anaerobically, extracted, and the resulting product was analyzed through 15N-NMR 
(Figure 2.5). The scans showed that the major product was PHA ( = -243.56 ppm), with 
trace amounts of AYB ( = -52.65, -52.96, -57.51, and -57.74 ppm). The formation of 
AYB is a common side-product that can be formed during the work-up of the sample 
when it is exposed to oxygen.172 Comparison with a standard solution of AN ( = -
325.10) confirmed that there was no amine production from the enzymatic reaction. 
Further studies with 1H-NMR supported the fact that it was indeed PHA being produced 
from the enzymatic reduction (data not shown). This is also in agreement with the recent 
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findings of Pitsawong et al., in which the NRentcl was shown to produce exclusively the 
hydroxylamine equivalent of 4-nitrobenzoate.173 
 
 






Figure 2.6 LC-MS analysis of NRsalty product. 1 mM 4- nitrobenzenesulfonamide (4-
NBS), 5 U.mL-1 glucose dehydrogenase (GDH), 10 M NAD+, 10 mM dextrose, and 1 
M NR in 50 mM Tris-Cl (pH 7.5).  
 
HPLC and LC-MS were implemented to develop a more practical analytical tool 
for the different nitroaromatics and its derivatives. Unsubstituted NB and its reduced 
forms are difficult to analyze on HPLC and LC-MS for the following reasons: i) AN is 
very basic, and cannot be retained on regular C18 columns, and ii) MS detection through 
Electrospray ionization (ESI) requires the target molecule to have ionization sites for 
protonation or deprotonation, where NB and its derivatives lack these characteristics. To 
overcome these issues 4-nitrobenzene sulfonamide (4-NBS) and 4-nitrobenzoic acid (4-
NBA) were selected and synthesized as model substrates for these studies. Reduction of 
these substrates with NR yielded the hydroxylamines as the product both on HPLC and 




2.3.5 Possibility of Amine Formation 
As previously discussed, most NRs have been shown to reduce nitroaromatics to 
hydroxylamines as final products. There are a couple of exceptions including NRmycsm 
from M. smegmatis and NR from Streptomyces mirabils DUT001 (NRstrmi). In the first 
example, M. smegmatis was found to be immune against the anti-tuberculosis 
benzothiazinone drug, BTZ043 (9). This resistance was identified to be caused by 
NRmycsm, which was capable of reducing the nitro drug to the corresponding amine, 
BTZ045, as the major product, rendering it inactive.29 In the second example, Yang et al. 
showed that the soil bacterium Streptomyces mirabils DUT001 was able to reduce 4-
nitro-1,8-naphthalic anhydride (4-NNA) to its corresponding amine and identified a 
NRstmi that was responsible for this transformation.33,174 
 
 
Figure 2.7 Nitroaromatic substrates used for product distribution studies 
 
Based upon these examples, two hypotheses were estabilished: i) specific 
enzymes are able to reduce nitroaromatics to the amine, and/or ii) there are certain 









































To test these hypotheses, NRsalty and NRmycsm were utilized for the reduction of 
different nitroaromatics (Figure 2.7). To use minimal cofactor and drive the 
thermodynamic equilibrium for these reactions, an NADH recycling system using 
glucose dehydrogenase (GDH) was implemented. After an overnight reaction, the 
product was analyzed via HPLC and LC-MS. 
 
Table 2.2 Substrate Study for Nitro Reduction.  
 Name Product Analytical toolsa Detection 
1 nitrobenzene -NHOH HPLC (40%) 235 & 265 nm 
2 4-nitrobenzoic acid -NHOH HPLC (30%) 280 nm 




4 1-nitronaphthalene  -NHOH HPLC (40%) 215 nm 
5 3-nitrobenzotrifluoride -NHOH HPLC (50%) 245 nm 
6 nitrofurazone -NHOH/-NH2 HPLC (15%) 
LC-MS (20%) 
260 & 300 nm 
(+)-mode 




8 4-nitro-1,8-naphthalic anhydride -NHOH/-NH2 HPLC (50%) 
LC-MS (50%) 
270 & 345 nm 
(+)-mode 
apercent of acetonitrile for the mobile phase with the make-up solvent as water 
 
For most substrates both enzymes generated results similar to previous findings; 
the nitroaromatics were reduced to the hydroxylamine. 3-Nitrobenzotrifluoride was 
studied to see if the trifluoromethyl (–CF3) substituent on BTZ043 (9) is responsible for 
amine production. Comparison of the enzymatic product and chemically synthesized 
standards showed that the corresponding hydroxylamine, N-hydroxy-3-(trifluoromethyl)-
benzenamine, was produced. This implies that the –CF3 substituent alone is insufficient, 
and the conjugated ring system of BTZ043 is necessary for the reduction to amine.  
Interestingly, 4-NNA (8), the only substrate shown to be reduced to the amine 
with a single enzyme among the ones tested, showed to produce the amine, albeit in very 
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small quantities. Hypothesizing that bulkier substrates with more aromaticity are 





Figure 2.8 Proposed fragmentation of nitrofurazone and its corresponding amine. 
 
Additionally, reduction of nitrofurazone (NFZ, 6), while mostly resulting in the 
hydroxylamine, also produced a minute amount of aminofurazone (AFZ). To confirm the 
formation of AFZ both the substrate and product were analyzed using Mass spectrometry 
(MS) fragmentation and the resulting fragmentation patterns were compared. The major 
fragmentation masses for nitro- and aminofurazone were 182 and 126, respectively. The 
mass difference of the major fragment can be explained by comparing the change in 
resonance effect by the redox state (Figure 2.8). It is presumed that the electron-
withdrawing effect of NFZ will make the imine nitrogen of the semicarbazone weakly 
basic, promoting rearrangement to release ammonia. AFZ will have the opposite outcome 
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since the amine group is electron-donating. This will cause the compound to rearrange 




Figure 2.9 Updated reaction pathway of NB with NR. 
 
The reaction pathway for NRsalty was found to be similar to that of previously published 
NRs (Figure 2.9).40 The first reduction step from nitro to nitroso is relatively slow 
compared to the second step of nitroso to hydroxylamine. Molecular oxygen was 
identified as the cause for PHA oxidation to NOB, leading to the production of AYB. 
This side-reaction could be prevented effectively by performing the reactions 
anaerobically. Also, it was confirmed through 15N-NMR and HPLC that the enzymatic 
product from NB was PHA, not AN. Previous detection of AN was an artifact of the GC 
analysis where the unstable PHA chemically reacted to form several products, among 
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them the amine. For analytical purposes, subsequent studies in this thesis were carried out 
with either 4-nitrobenzoic acid (4-NBA) or 4-nitrobenzenesulfonamide (4-NBS) 
The reason for limited examples of amine production was investigated to define 
whether it was dependent on the enzyme and/or substrate. Reduction of an array of nitro 
substrates with NRsalty and NRmycsm suggested that the selectivity is unlikely to be 
dictated by the enzyme alone. Rather, there seems to be a relation with substrate features. 
A systematic approach with derivatives of BTZ043 may help understand the exact 




3HAMMETT CORRELATION IN BIOCATALYTIC 
NITROAROMATIC REDUCTION 
 
3.1 Introduction & Motivation 
As discussed in Section 1.3.2, enzymatic reduction of nitro aromatics has been focused in 
the field of bioremediation. For such applications the molecule of interest commonly has 
multiple nitro groups on the benzene ring such as trinitrotoluene (TNT). Therefore, 
information available in the literature focuses on such compounds. There have been some 
instances where a large scope of substrates were studied, one example being the work of 
McCormick et al.175. However, these studies were in the context of cell free extract and 
only compared the reaction rate at one given condition, making it difficult to infer these 
results directly to single enzymes. Hence, a systematic approach, such as a quantitative 
structure–activity relationship (QSAR), will be immensely helpful in understanding and 
characterizing the substrate specificity of NRs. 
 In this study, the kinetic properties of previously discussed NRs, NRsalty from 
Salmonella typhimurium and NRmycsm from Mycobacterium smegmatis, were 
investigated. Additionally, the substrate specificity of both enzymes were explored over a 
broad range of substituted nitro compounds and characterized according to QSAR 
relationships. Overall, the target of this study was two-fold: gain better understanding of 





3.2 Materials & Methods 
3.2.1 Enzymes and Chemicals 
Enzymes were expressed and purified as described previously (Chapter 2). All chemicals 
such as substituted nitro compounds and salts used for buffers were obtained from 
Sigma-Aldrich (St. Louis, MO). 
3.2.2 Enzyme activity assays 
Initial specific activity measurements were conducted on a DU 800 spectrophotometer 
(Beckman Coulter; Brea, CA). Studies were performed with 0.1 M enzyme, 0.5 mM 
NADH, and 0.1 mM nitro substrate at 25 °C. Oxidation of the cofactor NADH was 
monitored at 370 nm (  = 2,660 M-1.cm-1).176 
 To determine the apparent NAD(P)H Michaelis-Menten kinetic parameters, kcat 
and , 2,4-dinitrotoluene (2,4-DNT) was used as a model substrate. A range from 
0.013 to 0.5 mM and 0.05 to 2 mM was used for NADH and NADPH, respectively. 
When studying NRsalty, a range from 12.5 M to 12 mM was studied for each 
substituted nitro compound depending on its solubility with 0.5 mM NADH. A baseline 
rate of NAD(P)H consumption was measured prior to addition of nitrosubstrate in order 
to account for NAD(P)H oxidation activity. For NRmycsm, a microtiter plate (MTP) 
assay was used with a Synergy H4 Multi-Mode Plate Reader (BioTek; Winooski, VT) in 
96-well plates. Substrate concentrations ranging from 0.01 mM to 4 mM were studied to 
measure the kinetic parameters. 
 pH dependence of the enzyme kinetics were investigated by using 4-nitrobenzene 
sulfonamide (4-NBS) as a model substrate for NRsalty, and using 4-nitrobenzonitrile (4-
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NBN) for NRmycsm. Buffers used for these studies were 50 mM citrate (pH 5-6), Bis-
Tris-Cl (pH 6-6.5), Tris-Cl (pH 7-9), carbonate (pH 9-10). 
3.2.3 Data analysis and fitting 
 Data were fit with OriginPro (v 9.0.0) software (OriginLab; Northampton, MA). Kinetic 
data for NAD(P)H and nitro substrates were fit according to the Michelis-Menten 
equation (Equation 3.1) where one substrate was varied while the other was fixed.177  is 
the reaction rate, 0 is the enzyme concentration and  is the varied substrate 
concentration. Equation (3.1) simplifies to equation (3.2) when the substrate 
concentration is much lower than . The pH dependencies of steady-state kinetic 
parameters were fit with either equation (3.3), which describes a curve with unit slope on 
both sides of a plateau, or equation (3.4), which is simplified from equation (3.3) and 
applicable when the curve is present in the acidic region and the plateau is in the basic. 
,  and ,  are the dissociation constants of the functional groups that are important for 
catalysis. Y is  or / , and C is the pH-independent value of the kinetic 





















3.3 Results & Discussion 
3.3.1 NAD(P)H kinetics and preference 
A study was conducted to characterize each enzyme’s preference for the nicotinamide co-
substrate (for pH and activity profiles of NRmycsm see Appendix D). Kinetic parameters 
of the co-substrate NAD(P)H were obtained with 2,4-dinitrotoluene (2,4-DNT) as a fixed 
substrate, and fit according to the Michaelis-Menten equation (Table 3.1). NRsalty 
displayed a high  when utilizing NADPH compared to NADH. However, the 
 value (189 μM) was much larger compared to  value (39.3 μM). Further 
comparison of /  and /  indicated that NADH is preferred as the 
co-substrate. For NRmycsm there was no preference between NADH and NADPH. 
Based on these findings subsequent substrate studies were carried out with NADH at 0.5 
mM.  
 
Table 3.1 Apparent kinetic parameters for NAD(P)H with 2, 4-DNT as a fixed substrate 
(not saturating conditions for 2, 4-DNT) 













NRsalty 57 ± 2 39 ±   6 1.45 ± 0.23  104 ± 4 189 ± 23 0.55 ± 0.07 






Figure 3.1 pH dependence of log	 /  and log	  for NRsalty (black) and 
NRmycsm (red) with model substrates of 4-NBS and 4-NBN, respectively. Data were fit 
with equations (3.3) and (3.4). 
 












































3.3.2 pH dependence of  and /  
The effect of pH on the steady-state kinetic parameters was determined for both NRsalty 
and NRmycsm (Figure 3.1). For NRsalty both  and /  decrease in the 
acidic region and shows more less an identical p ,   of 5.5. This phenomenon indicates 
that either there is a deprotonated residue that is important for a catalytic step occurring 
between substrate binding up through the first-irreversible step or that the enzyme is 
unstable at lower pH. A homology structure of NRsalty was designed using 
ESyPred3D178 with NRentcl (PDB ID: 1KQC) 42, which shares an identity of 88.9%, as a 
template. This structure was searched for histidine (p  = 6.1), glutamate (p  = 4.1) and 
aspartate (p  = 4.1) as possible candidates for the deprotonated residue. Interestingly 
Glu165 and His128 were found to exist in close proximity (4.5 and 6.5 Å) to the substrate 
binding site. Glu165 is conserved throughout NRs from E. cloacae, E. coli and S. 
typhimurium and its amine backbone has been proposed to serve as a hydrogen bond 
donor for the N5 position of the flavin (3.1 Å) according to previously published three-
dimensional structures.42,44 The structure of NRmycsm (PDB ID: 2WZW)29 was also 
examined as it exhibits a p ,  < 6.0 for / . However, none of the three 
residues (His, Glu and Asp) were found within 10 Å of the active site. This lack of such 
residues suggests that if both enzymes have identical catalytic mechanisms the observed 
decrease in  and /  and /  is likely due to pH instability. 
NRsalty had an additional p ,  of 8.8 ± 0.1 in the basic region of the  values. 
The p  from NRsalty can be indicative of a residue necessary for catalysis or it can be 
from the deprotonation of the substrate 4-nitrobenzenesulfonamide (4-NBS) as the 
substrate has a sulfonamide moiety (p  = 9.48).179 This sulfonamide group does not 
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participate in the reaction, but the change in charge can easily change the transition state 
stabilization pattern. Compared to NRsalty that displays a basic p , the  of 
NRmycsm is independent of pH throughout the studied region. The the lack of a p  can 
be interpreted as a difference in the rate-limiting step between the enzymes. For example, 
NRsalty will be exhibiting the p  because the chemical step is partially rate-limiting, 
whereas NRmycsm will be pH independent because a there is a step slower than 
catalysis, such as product release, which is fully rate limiting. To investigate whether the 
p  is from the substrate or enzyme two sets of approaches can be proposed. The first is 
measuring the  of NRsalty with a different but similar substrate that has no difference 
in protonation state at basic pH to identify if the p  comes from the substrate. The 
second way to identify the source of the p  is to identify residues in the active site that 
could contribute to the p  at 8.8 and mutate it to a different, but similar, amino acid in 
order to shift the pKa. Within 5 Å of the substrate binding site only one residue, Lys14, is 
a candidate, and mutating this residue to an Arg should help verify if this residue is 
catalytically active. Additionally, further studies with stopped-flow kinetics are required 
to identify rate-limiting steps at each pH for a more in depth understanding of the 
mechanism. 
3.3.3 Specific activity of substituted nitroaromatics 
To study the substrate spectrum of NRs kinetic assays to monitor NAD(P)H oxidation 
were performed with UV-visible spectroscopy at 370 nm ( = 2,660 M-1.cm-1), rather 
than 340 nm (  = 6,220 M-1.cm-1). This was done to i) avoid absorbance overlap from 
the nitroaromatic substrates, and ii) accommodate higher NAD(P)H concentrations. 
Preliminary specific activity measurements were performed with 0.5 mM NADH and 0.1 
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mM substrate. Initial specific activity studies included a variety of nitrobenzenes with 
electron-donating and withdrawing substituents at the meta- and para-positions. 
Substrates with ortho-substitutions were excluded as steric effects could lead to 
complications. The NADH oxidase activities were measured by monitoring the 
NAD(P)H oxidation in the absence of nitro substrates, and subtracted as background 
activity (less than 3% activity compared to slowest nitro substrate). This measure was 
taken to correct for the presence of molecular oxygen which is an additional substrate that 
can consume the cofactor, as these experiments were conducted under aerobic conditions. 
 
 
Figure 3.2 Specific activity of NRsalty and NRmycsm plotted according to the Hammett 
equation 
 
 For both enzymes, it was observed that substrates with stronger electron-
withdrawing groups had higher specific activity, which is in agreement with previously 
published literature.56,175,180 These observations were investigated for any potential 
quantitative structure-activity relationships (QSAR) by separating the substrates 
according to the substituent position relative to the nitro group, meta- and para-, and 







































plotting the results according to their Hammett substituent constants and relative specific 
activities (Figure 3.2).181,182 Regardless of the substituent position, it was clear that the 
activities had a QSAR which lead to the hypothesis that the kinetic parameters, namely 
 and / , can be characterized with the Hammett correlation. 
3.3.4 Hammett Correlation 
The Hammett equation was developed to explain the effect of a substituent on reaction 
rates and equilibrium constants as a linear free-energy relationship.183 This was 
developed using ionization of benzoic acids as a model system, where Hammett himself 
studied many benzoic acid derivatives to measure the effect of the different 
substituents.184 The relationship was described through the following equation, 
 log   ( 3.5)
where k is the reaction rate with a substituent, and  is the value of the unsubstituted 
moiety. The Hammett substituent constant, σ, captures inductive and resonance effects 
within the substrate whereas the Hammett reaction constant, ρ, represents the nature of 
the reaction. A positive ρ indicates that a negative charge is created or a positive charge is 
lost in the transition state. The opposite holds when ρ is negative, and when there is no 
change in charge ρ will be zero.  
 To characterize the NRs according to the Hammett relationship, kinetic 
parameters were developed with various para-substituted nitroaromatics according to the 
Michaelis-Menten model (Table 3.2). These measurements were taken at pH 7.5 where 
the enzyme kinetics is independent of pH. For NRsalty, it was impossible to elucidate 
 and  in certain cases as the activity did not reach saturation before encountering 
solubility limits. Instead, /  was measured from the linear increase of activity with 
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increasing substrate concentration, where the Michaelis-Menten model simplifies to 
equation (3.2).  
 
Table 3.2 Kinetic parameters for various substituted nitroaromatics 
NRsalty     
Substituent Sigma (σ)  (s-1)  (mM-1) /  (s-1.mM-1)
-H 0 - - 1.7 ±   0.1 
-COO¯ 0 5.8 ±   0.3 1.13 ± 0.11 5.1 ±   0.6 
-Cl 0.23 - - 5.2 ±   0.2 
-COOCH3 0.45 - - 84.5 ±   6.8 
-COCH3 0.5 166   ± 25 0.99 ± 0.28 167    ± 54 
-SO2NH2 0.6 182   ± 11 1.68 ± 0.29 108    ± 20 
-CN 0.66 290   ± 13 1.22 ± 0.10 238    ± 22 
-SO3CH3 0.9 275   ± 22 0.74 ± 0.17 373    ± 90 
     
NRmycsm 
Substituent Sigma (σ)  (s-1)  (mM-1) /  (s-1.mM-1)
-H 0 3.4 ± 0.4 2.82 ± 0.61 1.2 ±   0.3 
-Cl 0.23 4.5 ± 0.5 0.39 ± 0.14 11    ±   4 
-COOCH3 0.45 9.0 ± 0.3 0.12 ± 0.01 75    ±   7 
-SO2NH2 0.6 17.2 ± 0.9 0.19 ± 0.02 91    ± 13 
-CN 0.66 16.0 ± 1.0 0.14 ± 0.03 111    ± 22 





Figure 3.3 Hammett plots for a) NRsalty and b) NRmycsm. 
(■ and ■): log	 / /	 / ; (○): log	 /	  
 


























































 When plotting the kinetic data as a function of the Hammett equation, both 
enzymes showed to have a Hammett reaction constant, ρ, of roughly 3 for their 
log	 ⁄ / ⁄  relationship. These comparable ρ values indicate that the 
characteristic of the transition states produced by the two different enzymes is 
nonetheless similar. However, it can also be argued that there is a change in the 
substituent effect ρ for NRmycsm. Here, two linear regressions can be plotted with = 
0.45 as the transition point where the nature of either substrate binding or the first 
irreversible-step in overall steady-state kinetics changes. Although it is unknown what 
part of catalysis is being affected, there is a possibility that this phenomenon can be 
related with steric effects of the lower  substrates which are generally smaller in size. 
The hypothesis will be that initially the substituents improve binding drastically, but this 
improvement becomes insignificant once the substrate becomes bulkier. Notably, the	  
value of the unsubstituted nitrobenzene is much higher compared to those with 
substituents. For higher   substrates the increase would then be a result of transition state 
stabilization of the first irreversible-step. To rule out substrate binding as the cause for 
this transition point, additional experiments to study the substrate binding affinity ( ). 
Such experiments will include measuring the substrate kinetic rates while varying 
inhibitor concentration or monitoring the flavin fluorescence quenching while varying the 
substrate concentration. 
 Overall, the Hammett correlation supports our hypothesis that electron-
withdrawing groups stabilize the transition state formed by the enzymes. This implies 
that the transition state involves accumulation of excess electron density. Therefore, 
 
 51
when selecting substrates for reduction, it is important to note that those with a larger σ 
can be expected to be better substrates.  
 
3.4 Conclusion 
In summary, the pH dependencies of NRsalty and NRmycsm revealed that there is an 
acidic p  that is important for a phenomenon occurring before the first irreversible-step. 
However, the lack of a similar residue in both substrates suggests that it may be due to 
enzyme instability at acidic pH values. Further, the absence of a basic p  for NRmycsm 
indicates that product release may be rate-limiting. Both NRsalty and NRmycsm exhibit 
better catalytic reduction of substrates with electron-withdrawing substituents para- to 
the nitro group. This phenomenon was analyzed via the Hammett equation wherein 
NRsalty showed a linear increase of log	 ⁄ / ⁄  , but NRmycsm 
showed a possible change in either substrate binding or transition-state stabilization. 
Additional studies on NRmycsm are necessary to understand each catalytic step 
independently to test the hypothesis: at low  the substrate binding is affected and 
substantially improves ⁄ , whereas at high  the extent of transition state 
stabilization of the first irreversible-step by electron-withdrawing groups dictates 






4ENZYMO-CHEMICAL SYNTHESIS OF AMINES 
 
4.1 Introduction & Motivation 
As discussed in Chapter 2 many of the currently studied NRs produce the hydroxylamine 
as the final product. As the pharmaceutically interesting compounds are amines, it is 
necessary to develop a way to further reduce the hydroxylamine. One method to achieve 
this goal is to pair enzymatic reduction with chemical reduction. Examples of combined 
enzymatic and chemical synthesis include deracimisation of D, L-amino acids using 
amine-boranes and L-amino oxidase, chiral alcohol synthesis with palladium and alcohol 
dehydrogenase, and synthesis of asymmetrically branched N-glycans with 
glycosyltransferases from chemically synthesized glycan precursors.185-187 In all these 
cases, the enzymatic step follows the chemical ones (and usually introduces the chirality); 
therefore, the processes are termed chemoenzymatic processes. Here, a system was 
designed to utilize NRs in conjunction with simple reducing agents for a sequence of 
enzymatic reductions followed by a chemical reduction; this sequence therefore is termed 
enzymo-chemical reduction (Figure 4.1). 
 
 





4.2 Materials & Methods 
4.2.1 Chemicals 
Substrate and product standards such as 4-nitrobenzoic acid, 4-nitrobenzene sulfonamide, 
4-aminobenzoic acid, and sulfanilamide, and reducing agents including sodium dithionite 
(sodium hydrosulfite), formamidine sulfinic acid (thiourea dioxide), amine-borane, and 
sodium cyanoborohydride were purchased from Sigma-Aldrich (St. Louis, MO). 
Sodium 4-nitrobenzoate was prepared by dissolving 4-nitrobenzoic acid in ethyl 
acetate. The dissolved compound was precipitated as a sodium salt with the addition of a 
10 N NaOH solution. The resulting crystals were filtered, washed with additional ethyl 
acetate and vacuum dried. 
All other material is discussed in section 2.2.1. 
4.2.2 Reducing agent screening 
Reducing agents sodium dithionite (SD), formamidine sulfinic acid (FSA), ammonia 
borane, sodium cyanoborohydride, and sodium formate were incubated with either 1 mM 
of 4-(hydroxyamino)benzoic acid or 4-(hydroxyamino)benzene sulfonamide at a final 
starting concentration of 5 mM. After 5 h of incubation the reaction mixtures were 
analyzed using HPLC. For SD and FSA, experiments were repeated anaerobically in a 
Coy anaerobic chamber (Grasslake, MI). FSA reduction temperature dependence was 
studied by varying the incubation temperature at 25, 37, 60, 80 °C. The reaction was 






4.2.3 HPLC analysis 
4-Nitrobenzoic acid and 4-nitrobenzene sulfonamide, and their reduced states were 
analyzed using HPLC (Shimadzu; Kyoto, Japan). Analysis was conducted with a 
Shimadzu LC-20AT pump, Phenomenex Luna® 5 µM C18 100 Å 250 x 4.6 mm, and 
SPD-M20A prominence diode array detector (PDA). Separation was achieved with an 
isocratic flow of water:acetonitrile (70:30) at a flow rate of 1 mL.min-1. Retention times: 
4-(hydroxyamino)benzoic acid 3.65 min, 4-aminobenzoic acid 4.26 min, 4-nitrobenzoic 
acid 15.5 min monitored at 280 nm; 4-(hydroxyamino)benzenesulfonamide 3.33 min, 4-
sulfanilamide 3.66 min, 4-nitrobenzenesulfonamide 9.34 min monitored at 260 nm. 
4.2.4 Enzymo-chemical reduction 
Nitroreductase from Salmonella typhimurium (NRsalty) was purified as discussed 
previously (Section 2.2.3). Enzymatic reduction was performed at a 1 mL scale with a 
final concentration of 1 mM substrate (pre-dissolved as 200 mM in DMSO), 1 M 
NRsalty, 2.5 U.mL-1 glucose dehydrogenase (GDH), 10 mM dextrose, and 0.1 mM 
NAD+. After 1 h, chemical reduction was initiated by an addition of 5 mM FSA and 1 M 
HCl, and incubated at 60 °C. The reaction mixture was diluted in half with HPLC 
acetonitrile, centrifuged at 13793 g for 5 mins, and then analyzed using HPLC.  
4.2.5 Large Scale Synthesis 
75 mM Sodium 4-nitrobenzoate (1.42 g, 7.5 mmol) was dissolved and reduced in 100 mL 
of 100 mM NaPi buffer with a GDH recycling system (250 mM dextrose, 1 mM NAD+, 
10 U.mL-1 GDH), and 5 M of NRsalty for 6 h. The resulting hydroxylamine was further 
reduced with the direct addition of HCl and FSA to a final concentration of 1 M and 250 
mM, respectively, and incubated at 60 °C for 12 h. The reaction product was extracted 
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three times with ethyl acetate (50, 25, and 10 mL), dried over MgSO4, and filtered. The 
product was recovered through rotary evaporation with a final mass of 0.94 g. 
4-amino-benzoic acid: 1H NMR (400 MHz, DMSO-d6): δ 12.00 (s, 1H, OH), 7.58 
(d, 2H, J = 8.8 Hz, CH), 6.51 (d, 2H, J = 8.8 Hz, CH), 5.87 (s, 2H, NH). 
 
4.3 Results & Discussion 
4.3.1 Sodium dithionite 
Sodium dithionite (SD) was selected as the initial reducing agent as Powell et al. showed 
that it can be used to reduce N-nitrosotetrahydroisoquinoline to its corresponding 
amine.188 Preliminary experiments were conducted by reducing 4-(hydroxyamino)-
benzoic acid while varying the amount of SD. HPLC analysis of the reaction showed that 
the addition of SD converted –NHOH to –NH2. However, about 60% of the starting 
material converted to side-products in the reaction. These side-products were presumed to 
be charged and hydrophobic based on their HPLC elution times and immiscibility in 
organic solvents. One possible side-product can be the sulfamic acid that has been 
proposed to form from an aromatic hydroxylamine.189 Additionally, as dithionite is 
known to react with molecular oxygen to create radicals, there is concern that this will be 
the cause of side-product formation. To avoid such complications, experiments were 
repeated in anaerobic conditions, but no significant difference was detected in the product 







Figure 4.2 Proposed setups for combining the enzymatical and chemical reactions 
 
4.3.2 Overall scheme of reduction 
To investigate feasibility of combining the enzyme and chemical reactions, two setups 
were proposed for amine production (Figure 4.2). The first was a single-batch reaction 
where all components were combined from the beginning. The second was a two-step 
synthesis where the enzymatic reduction with NR takes place, followed by the addition of 
the reducing agent to complete the production of amine. Here, the first approach failed to 
effectively convert the nitro substrate to the hydroxylamine, limiting the overall 
conversion (less than 20% conversion). This can be understood in conjunction with the 
fact that SD is known to create radicals that can deactivate enzyme by reacting with the 
flavin cofactor.190 Moreover, SD can react with the nitro substrate to create a radical-
anion which in turn produces superoxide from oxygen, opening up additional possibilities 
to deactivate the enzyme.191,192 In the second system, full conversion of the nitro to 






















selectivity limitations. Concerns regarding the product selectivity and SD oxygen 
sensitivity lead to a continued search for reducing agents. 
4.3.3 Screening reducing agents 
Additional reducing agents were screened based upon previous literature examples of 
imine and oxime reduction. These included formamidine sulfinic acid (FSA) 193, amine-
borane 194, and sodium cyanoborohydride 195. They were tested for the chemical reduction 
of hydroxylamine (Table 4.1). FSA was able to reduce to the amine with a yield of 
roughly 30%. However, ammonia-borane and sodium cyanoborohydride showed no 
reactivity towards the hydroxylamine. 
 
Table 4.1 Preliminary screen of reducing agents. 
Reducing Agent Formula Amine yield (%) 
Sodium Dithionite Na2S2O4 36 
Formamidine sulfinic acid NH2C(=NH)SO2H 31 
Ammonia-borane BH3NH3 0 
Sodium cyanoborohydride NaBH3CN 0 
 
4.3.4 Optimization of formamidine sulfinic acid (FSA) reduction conditions 
The redox potential of a reducing agent is known to be dependent on the temperature and 
pH of the solution. Previous studies with FSA have shown that its redox potential 
becomes increasingly negative with increasing temperature and decreasing pH.196 To 
investigate whether this influences the conversion, different temperatures and pH values 




Figure 4.3 Production of amine with FSA while varying the pH value (50 mM buffer) 
and acid type (1 M) at 60 °C 
 
Temperatures of 25, 37, 60 and 80 °C were tested; largest amounts of amine were 
observed at 60 and 80 °C. Although FSA has been shown to reduce nitroaromatics to 
amines under basic conditions, the selectivity is lost as carbonyl groups will be reduced 
to alcohols.193,197-199 Additionally, basic conditions are unfavorable for liquid-liquid 
extraction of certain substrates that have p  values less than 12, as they would be 
charged under basic conditions and thus not extract into the organic phase. Therefore, the 
pH study was limited to neutral and acidic conditions. Solutions with a pH value of 0, 4, 
6, 8, and 10 were tested, and the most acidic condition was found to work best (Figure 
4.3). To understand if the type of acid had a significant impact several different types 
were screened at a constant concentration of 1 M. Among those, only HCl had a 
significant impact on the amine yield (Figure 4.3). The results for formic acid and acetic 
acid are not surprising as both have higher p  values (3.75 and 4.75, respectively) than 
 


















































HCl (p  = -7). At 1M concentration formic and acetic acid solutions will result in 
overall pH values of 1.9 and 2.4. However, it is intriguing that the comparably strong 
acid H2SO4 (p  = -6.62) did not exhibit high yields. A speculative reasoning can be 
placed based on the fact that sulfuric acid is an oxidizing acid, which can interfere with 
the reducing mechanism. The possibility of aromatic nitro reduction with FSA was 
examined to ensure that the complete reaction would not occur under acidic conditions 
and higher temperatures (i.e. to confirm that the enzyme reduction was still necessary). 
The nitro group was unaffected during reductions indicating that the hydroxylamine is 
selectively reduced in acidic conditions (data not shown). Based on these results 
subsequent chemical reduction with FSA was carried out with the addition of 1 M HCl, 
and incubation at 60 °C. 
4.3.5 Enzymo-chemical reduction  
Enzymo-chemical reduction of 4-nitrobenzoic acid was achieved as a one-pot two-step 
synthesis with NRsalty and FSA (Figure 4.4). Without the addition of FSA, there was no 
amine found in the reaction. When reduction with FSA was initiated, the amount of 
hydroxylamine immediately decreasing while the final product was confirmed as 4-





Figure 4.4 One-pot two-step reduction of 4-nitrobenzoic acid with NRsalty reduction to 
–NHOH and addition of FSA at 60 mins; (■): -NHOH; (□): -NH2; solid line: after 
addition of FSA; dotted line: control experiment (no addition of FSA after 60 mins); 
conditions: 60 °C, pH 0, [FSA] 5 mM, relative molarity [FSA]/[NHOH] = 5. 
 
4.3.6 Scale-up of synthesis  
Enzymo-chemical reduction was scaled up to a gram scale, where the reduction was 
carried out at a 100 mL reaction volume. 4-Nitrobenzoic acid was converted to its sodium 
salt and used as the starting substrate. The higher solubility of the sodium salt greatly 
increased the substrate availability in aqueous solution. 1.42 g of sodium 4-benzoic acid 
was reduced with 5 μM NRsalty in the presence of a GDH recycling system. The reaction 
was monitored via HPLC and when conversion of the nitro substrate to hydroxylamine 
was complete the chemical reaction was initiated with the addition of FSA and HCl. 
After overnight incubation at 60 °C the product was extracted with ethyl acetate and dried 
with MgSO4. Solid crystals were obtained through rotary evaporation and analysis of the 
 























isolated dry product was performed via 1H-NMR (Figure 4.5)  and HPLC (Figure 4.6). 
Comparison with 4-aminobenzoic acid authentic standards revealed that the product was 
indeed the amine. Most importantly, the appearance of the NH protons was notable from 
the NMR spectrum. A total mass of 0.94 g was obtained from the reaction. Excluding a 
minor amount of residual ethyl acetate (1.3 % w/w) the isolateed yield was 90.2%. 
 
 
Figure 4.5 1H-NMR spectra of 4-aminobenzoic acid in DMSO-d6 
 
20140218_p-ABA from reaction.esp































In summary, this study has identified sodium dithionite (SD) and formamidine sulfinic 
acid (FSA) as effective reducing agents for the reduction of hydroxylamines to the 
corresponding amines. Further optimization of reduction with FSA in acidic conditions 
and elevated temperatures demonstrated an amine production with high yield (>80%). 
Importantly, the acidic conditions helped preserve the selective hydroxylamine reduction, 
whereas in basic conditions the carbonyl groups can possibly reduce to alcohols.197,199 A 
one-pot two-step enzyme chemical reduction was conceived and proven to work as 
anticipated. Scale-up was attempted with sodium 4-nitobenzoate as a substrate, and from 
here, 90.2% was recovered as the 4-aminobenzoic acid.  
  
 














5ENGINEERING TOWARDS NITROREDUCTASE 
FUNCTIONALITY IN ENE-REDUCTASE SCAFFOLDS 
 
5.1 Introduction & Motivation 
As previously discussed in Chapter 1, both nitroreductases (NRs) and ene-reductases 
(ERs) utilize flavin mononucleotide (FMN) as a cofactor, but catalyze distinct reactions. 
NRs are capable of reducing nitroaromatics to their corresponding hydroxylamines, and 
in rare cases the amine, while ERs are widely used to reduce alkenes with adjacent 
electron withdrawing groups such as aldehydes, ketones, esters, carboxylic acids and 
nitriles.102,103,200  
A pronounced difference in these enzymes lies in their distinct structures. NRs are 
homodimeric enzymes that have the FMN cofactor bound at the interface, where the 
active site is composed of residues from both monomers.42,43_ENREF_52 In comparison, 
ERs have a TIM barrel structure that can either exist as monomers, dimers, and other 
multi-oligomeric states.200,201_ENREF_51 The FMN cofactor is bound at the C-terminal 
of the barrel, which forms an active site, independently for each monomer. 
Interestingly, the functionality of these enzymes is known to overlap to some 
extent. NR from Salmonella typhimurium is known to reduce α, β-carbon double bonds 
with adjacent nitro groups, whereas OYE1 from Saccharomyces pastorianus, 
pentaerythritol tetranitrate (PETN) reductase from Enterobacter cloacae and xenobiotic 
reductase A (XenA) from Pseudomonas putida have been shown to reduce explosives 
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such as trinitrotoluene (TNT) through nitro reduction.39,202 However, the reason for this 
cross-selectivity has yet to be understood.  
Previously, Yanto et al. has shown that nitrobenzene conversion of xenobiotic 
reductase A (XenA) from Pseudomonas putida is higher when mutating cysteine at 
position 25 to glycine (C25G).203 This was chosen as a starting point to investigate the 
possibility of increasing NR functionality in ER scaffolds. The overall hypothesis for this 
work was that ER or NR functionality can be determined by a few active site residues 
such as C25G, and, thus, that variants of active site residues can lead to a switch in 
functionality. 
In this study, ERs KYE1 from Kluyveromyces lactis and YersER from Yersinia 
bercovieri are selected as model enzymes due to their high similarities to OYE1 and 
PETN reductase, respectively (for sequence similarities see Appendix B).116 Introduction 
of NR functionality into these enzymes is attempted through site-directed and iterative 
mutagenesis. The study focuses on two main goals: scientifically, we desire a better 
understanding of the governing factors in functional selectivity and from an engineering 
perspective, utilization of the monomeric scaffold is targeted for future applications 
where such a tertiary structure is beneficial.  
 
5.2 Materials & Methods 
5.2.1 Chemicals 
Ene-substrates ketoisophorone and 2-cyclohexen-1-one were purchased from Sigma-
Aldrich (St. Louis, MO) and TCI America (Portland, OR) respectively. All other 




Recombinant plasmid construction of KYE1 from Kluyveromyces lactis, YersER from 
Yersinia bercovieri and xenobiotic reductase A (XenA) from Pseudomonas putida has 
been described in previous studies and are summarized in Appendix C.116,203,204 Site-
directed mutations were introduced through overlap extension polymerase chain reaction 
(OE-PCR). Oligonucleotide synthesis and DNA sequencing were done through Eurofins-
MWG|Operon (Huntsville, AL). Primer sequences are described in  
Table C.3. 
5.2.3 Protein expression and purification 
XenA wild-type and the C25G variant were expressed and purified according to 
previously published methods with modifications.203 A HiPrep 16/10 QFF column (GE 
healthcare; Fairfield, CT) was used in place of the HiTrap Q XL, with a 50 mM NaPi 
buffer (pH 7.5) instead of Bis-Tris as the mobile phase. The concentration of NaCl was 
increased from 0 to 500 mM over 20 column volumes (CVs) for protein elution. 
Subsequent steps were performed as published.203 KYE1 and YersER were also 
expressed and purified according to previously published literature with an additional 1 h 
incubation with exogenous FMN prior to binding the protein to the Ni-NTA resin.116 
Variants were transformed into BL21(DE3) competent cells. For the variants of KYE1 
and YersER, different temperatures and isopropyl β-D-1-thiogalactopyranoside (IPTG) 
concentrations were used (Appendix E). Gene expression was induced with IPTG 
between an OD600 of 0.5 and 0.7. Expression times were 4 h at 37 °C, 8 h at 30 °C, and 
overnight at 18 °C.  
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Protein concentration was determined through the Bradford assay, and purity was 
analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE).163 FMN occupancy was measured as described before (Section 2.2.3). Active 
fractions were buffer exchanged using a PD-10 Desalting Column (GE Healthcare; 
Fairfield, CT) to 50 mM NaPi, 150 mM NaCl buffer (pH 8.0). Enzymes were stored at -
20 °C after addition of glycerol to 50% (v/v).  
5.2.4 Enzyme activity assays and data fitting 
Enzyme activity was determined by monitoring the oxidation of NADPH using UV-
Visible spectrometry with a DU 800 spectrophotometer (Beckman Coulter; Brea, CA). 
For ene-reductase activity assays, ketoisophorone (KIP) and 2-cyclohexen-1-one were 
selected as model compounds. Reactions were conducted in 50 mM NaPi buffer (pH 7.5) 
with 0.2 mM NADPH, 10 mM substrate, and 0.5 μM enzyme at 25 °C. NADPH 
oxidation was monitored at 340 nm (  = 6,220 M-1.cm-1). Nitroreductase activity was 
monitored with a specific activity assay described before with modifications (Section 
2.2.4). Reactions were conducted in a 50 mM NaPi buffer (pH 7.5) with 0.5 mM 
NADPH, 0.5 mM 4-nitrobenzenesulfonamide (4-NBS), and 0.5 μM enzyme at 25 °C. 
NADPH oxidation was monitored at 370 nm with an extinction coefficient, ε, of 2,660 M-
1.cm-1.176 All measurements were performed in triplicates. 
Assays to determine ,  and  were performed on the DU 800 
spectrophotometer (Beckman Coulter; Brea, CA). Reaction rates for NADPH were 
determined from 6 to 500 μM NADPH with 1 mM 4-NBS and 0.5 µM enzyme. Substrate 
kinetics was measured with 0.3 mM NADPH and 4-NBS ranging from 15 to 1250 μM. 
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The data were fit according to the Michaelis-Menten equation (Equation 3.1) using 
OriginPro (v 9.0.0) software (OriginLab; Northampton, MA).  
 
5.2.5 Product determination 
Overnight enzymatic reactions were performed with the following conditions: 1 mM 
substrate, 10 mM of dextrose, 0.1 mM NADP+, 2.4 U.mL-1 of GDH and 1 μM enzyme. 
For 4-NBS conversion studies, the reaction was quenched with an equal volume of 
acetonitrile, and the sample was centrifuged at 13,000 g for 2 min. The supernatant was 
analyzed via HPLC with methods described previously (Section 4.2.3).  
5.2.6 Circular dichroism (CD) 
Circular dichroism (CD) measurements were performed on Olis Multiscan (Bogart, GA). 
Protein ellipticity was monitored at either 220 or 230 nm, depending on the variant, from 
20 to 80 °C with a ramp of 1 °C.min-1. Data were normalized to represent the folded 
fraction of protein, and fit to a van’t Hoff equation using a two-state model. 
5.2.7 Fluorescence study 
Fluorescence of the FMN bound enzymes was measured on a Synergy H4 Multi-Mode 
Plate Reader (BioTek; Winooski, VT). Wild-type and variants were diluted to 6 μM and 
aliquoted into 96-well plates. Excitation spectra were recorded from 300 to 580 nm with 
an emission wavelength of 600 nm. Emission spectra were measured from 450 to 700 nm 
with excitation at 430 nm. Recorded spectra were normalized according to FMN 
absorbance measurements. 
 
5.3 Results & Discussion 
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5.3.1 Effect of C25G mutation for XenA 
The increase in conversion observed with XenA C25G by Yanto et al. could be from 
either activity or stability improvements. To understand the effect of the mutation, both 
enzymes were purified and studied for their activity towards 4-nitrobenzenesulfonamide 
(4-NBS) as a substrate. Steady-state Michaelis-Menten kinetics showed that the C25G 
variant had a higher  value of 8.9 s-1, but also a larger  value of 820 M 
compared to wild-type XenA. Overall, the /  increased by an order of 
magnitude with the C25G variant (Table 5.1, Figure 5.1). This finding confirmed that the 
higher conversion is most likely a result from increased activity, thus investigating 
stability changes as well were unnecessary. 
 
Figure 5.1 Specific activity dependence of XenA wild-type (WT) and variant C25G on 
4-nitrobenzenesulfonamide (4-NBS) as a substrate at 25 °C 
 
Table 5.1 Kinetics parameters of XenA wild-type (WT) and variant C25G 
Enzyme  (s-1)  (M) /  (s-1.mM-1)
 
























XenA WT 0.44 ± 0.03 388 ± 55 1.1 ± 0.2 
XenA C25G 8.9    ± 0.2 820 ± 31 11     ± 1 
 
 
Figure 5.2 Amino acid alignment of ERs compared to XenA C25G. For sequence 
information see Appendix B. 
 
5.3.2 Analogous threonine to glycine mutation 
Analysis of the XenA crystal structure (PDB ID: 3L68) indicated that distance between 
C25 and the N5 of FMN is 3.9 Å.205,206 In addition, amino acid sequence comparison of 
XenA to the ene-reductases OYE1, KYE1, PETN reductase and YersER revealed that 
these enzymes all have a threonine residue in place of a cysteine at the corresponding 
position (Figure 5.2). Increased activities observed from the C25G variant, lead to the 
hypothesis that mutating the analogous threonine to glycine (position T27 for YersER, 
and T37 for KYE1) will yield similar increase in NR activity. This mutation appeared 
promising given that NRs also have a glycine residue located in front of the N5 position 
of the flavin.42-44 It has been previously speculated that the glycine residue is necessary, 






Figure 5.3 Specific activity of YersER and KYE1 wild-type (WT) and Thr to Gly 
variants. Reactions conducted in 50 mM NaPi buffer (pH 7.5) with 0.5 mM NADPH, 0.5 
mM 4-nitrobenzenesulfonamide (4-NBS), and 0.5 μM enzyme at 25 °C 
 
 
Variants YersER T27G and KYE1 T37G were created through overlap-extension 
PCR, expressed, purified and studied to compare activity towards 4-NBS. Although both 
mutations showed a slight increase in NR activity, the magnitude was insufficient to 
conclude that this single mutation will solely be responsible for altering the specificity 
from ER to NR (Figure 5.3).  
5.3.3 Increasing the active site cavity 
Available OYE1, XenA and NRentcl crystal structures were scrutinized to find an 
alternative approach.42,206,207 Comparison of the binding pocket cavity revealed that the 
FMN in OYE1 was secluded within the structure compared to XenA, which has the 
cofactor visible from the environment (Figure 5.4). The fact that the binding pockets of 
NRs are also fairly large and exposed led to the hypothesis that the enzyme functionality 










































Figure 5.4 Substrate binding cavity comparison of OYE1 (PDB ID: 1OYB), XenA (PDB 
ID: 3L68) and NRentcl (PDB ID: 1KQB) (from left to right). Images rendered using 
Visual Molecular Dynamics (VMD).41 
 
 
Figure 5.5 KYE1 crystal structure with mapped site-directed mutagenesis approach. 
Image rendered using Visual Molecular Dynamics (VMD).41 Residues are colored 
according to the approach. orange: analogous to C25G in XenA; blue: increase binding 
pocket size; green: recover substrate interaction from loss of tyrosine (Y375); pink: 




Site-directed mutagenesis studies to confirm this hypothesis were focused on 
KYE1 as it has high similarity to OYE1. A homology structure of KYE1 was designed 
using ESyPred3D178 with OYE1 (PDB ID: 1OYB), which shares an identity of 71.5%, as 
a template (Figure 5.5). Key residues were searched within 5 Å of the bound inhibitor p-
hydroxybenzaldehyde. From this, F296 and Y375 were identified to block the active site 
entrance, and W116 was found to occupy a large amount of space in the substrate binding 
site. To minimize spatial constraints, each position was mutated to alanine. In addition, as 
Y375 is known to interact with the substrate through hydrogen bonding, two residues 
were selected for tyrosine mutations to compliment Y375A, in case the tyrosine is 
essential for substrate binding or catalysis.125,207,208 M39Y was selected based on the 
analogous tyrosine at the identical position for XenA, and W116Y was selected based 
upon the proximity of the residue.  
These single mutations were performed, and enzyme selectivity was measured by 
comparing specific activities towards ketoisophorone (KIP) for ER activity and 4-
nitrobenzenesulfonamide (4-NBS) for NR activity. Most variants exhibited an increase in 
NR specific activity with Y375A as the best variant with a specific activity of 0.31 U.mg-




Figure 5.6 Iterative mutagenesis to increase NR activity with 4-NBS as a substrate.  
 
Table 5.2 Summary of ER and NR specific activity. ER specific activity measured with 
10 mM KIP, 0.2 mM NADPH and NR specific activity measure with 0.5 mM 4-NBS, 
0.5mM NADPH. All reactions were performed with 0.5 µM enzyme in 50 mM NaPi 
buffer (pH 7.5) at 25 °C. Activity ratios were calculated by assuming 0.01 U.mg-1 for 
those with no detectable activity. Not detectable (N.D.) 
Enzyme ER (U.mg-1) NR (U.mg-1) (NR)2/ER ratio
WT 2.27 0.01 0 
T37G - 0.13 N.D. 
M39Y 1.97 0.08 0.003 
W116Y 0.39 0.25 0.17 
F296A 1.33 0.23 0.04 
Y375A 0.09 0.31 1.12 
T37G/Y375A N.D. N.D. N.D. 
M39Y/Y375A 0.37 0.74 1.49 
W116Y/Y375A N.D. 0.63 39.6 
F296A/Y375A 0.12 1.12 10.3 
H191A/F296A/Y375A N.D. 1.03 106 
 
 










































5.3.4 Iterative mutagenesis for activity improvement 
To study the additive and synergistic (i.e. better than additive) effects of the mutations, 
first round mutations were added to the Y375A variant. Among those, W116Y/Y375A 
showed additivity, while M39Y/Y375A and F296A/Y375A showed synergy from the 
coupled mutations (Figure 5.6). The highest achieved specific activity of 1.12 U.mg-1 was 
two orders of magnitude higher than that of the wild-type. The variant T37G/Y375A 
showed a dramatic decrease in activity. This may be in relation to loss of substrate 
affinity, as both residues are near the N5 and C6 of the isoalloxazine ring. The extra 
space can increase the , leading to a low specific activity at the studied substrate 
concentrations. 
5.3.5 Elimination of ER activity 
Full conversion of KYE1 ER to a NR was attempted by eliminating catalytic residues that 
were known to participate in alkene reduction, namely H191 and N194.125 Previous 
studies on PETN reductase showed that mutation of residues 181 and 184 (which 
correspond to 191 and 194 in KYE1), can have a major impact on the enzyme 
selectivity.209 Toogood et al. constructed a library through site-saturation mutagenesis 
and tested the reduction of nitrostyrenes. With some variants they were able to find an 
increase in oximes (product of nitro-reduction) and a decrease in alkanes (product of ene-
reduction) in the product distribution. Among the variants, those that had alanine at 
position 181 or 184 exhibited the highest oxime to alkane ratio (8.3 for H181A 0.36 for 
H184A and 0.14 for wild-type).209 Hence, mutations H191A and N194A were added as 
single and double mutations onto previously successful variants, M39Y/Y375A and 
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F296A/Y375A. In addition, single mutation variants were also generated to study their 
effect on NR activity. 
The mutation N194A did not have a significant impact on ER activity elimination 
(Table E.2). However, any variant that included H191A showed no activity towards KIP. 
The triple variant H191A/F296A/Y375A also showed comparable specific activity (1.03 
U.mg-1) towards 4-NBS, showing the complete switch from ER to NR activity (Figure 
5.6, Figure 5.7). The change in functionality was also characterized by taking a ratio of 
NR and ER activity. As this number alone will not be indicative of the absolute activity, 
(NR)2/ER  was used compare variants (Table 5.2). 
 
Figure 5.7 Switch of activity from ER to NR with KIP and 4-NBS as substrates, 
respectively. 
 
5.3.6 Functional, kinetic and thermal characterization of variants 
The variants with the highest NR specific activity (F296A/Y375A) and highest (NR)2/ER 
ratio (H191A/F296A/Y375A) were selected as the best variants, and further characterized 
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Functionality of each enzyme was studied by reacting model substrates and 
determining the products. NR activity was confirmed by reducing 4-NBS and analyzing 
the reaction mixture via HPLC. Production of 4-hydroxylaminobenzenesulfonamide was 
confirmed for both variants (Figure E.1).  
 







KYE1 Wild-type 43.5 ± 5.9 - - - 
F296A/Y375A < 10 317 ± 18 1.20 ± 0.02 3.8 ± 0.2 
H191A/F296A/Y375Aa 303 ± 61 115 ± 26 0.52 ± 0.03 4.5 ± 1.1 
aapparent kinetic constants 
 
Figure 5.8 Kinetics of KYE1 variants in 50 mM NaPi (pH 7.5) at 25 °C. (●): NADPH 
kinetics with 1 mM 4-NBS; (○): 4-NBS kinetics with 0.3 mM NADPH. 
 

































































































Kinetic parameters were measured while varying NADPH or 4-NBS, while 
keeping the other constant (Table 5.3). As oxygen is known as an electron acceptor for 
ene- and nitroreductases, NADPH oxidase activity was measured and subtracted in the 
absence of a nitro substrate. Variant F296A/Y375A showed an improvement in the 
 (< 10 μM) compared to wild-type (43 μM). Turnover, kcat, was measured to be 
1.20 s-1 and the nitro substrate Km was 317 M. The introduction of H191A to this variant 
resulted in a loss of affinity for NADPH. Within the range that was studied (up to 0.5 
mM), saturation of NADPH was not achieved. Measuring the NR activity at 0.3 mM 
NADPH yielded an apparent kcat of 0.52 s-1 and kcat/Km of 4.5 s-1.mM-1. It is expected for 
the turnover to be similar to that of the variant F296A/Y375A at saturating conditions. 
 
Figure 5.9 Temperature dependent unfolding of KYE1 wild-type and variants monitored 
using circular dichroism (CD) at 220 nm. 
 





































KYE1 Wild-type 47.5 ± 0.2 5.2 ± 0.3 
F296A/Y375A 45.2 ± 0.3 2.8 ± 0.1 
H191A/F296A/Y375Aa 46.6 ± 0.3 3.0 ± 0.2 
 
Circular dichroism (CD) experiments were performed to ensure that the mutations 
had no negative effects on their thermal stability. Wild-type and variants F296A/Y375A 
and H191A/ F296A/Y375A were subjected to a denaturation study with a thermal 
gradient of 1 °C.min-1 at 220 nm (Figure 5.9). The melting temperature (Tm) and melting 
enthalpy (ΔHm) of each protein was determined by fitting the data to a van’t Hoff 
equation assuming a two-state melting model. Compared to the wild-type (Tm = 47.5 °C), 
the Tm of both the double variant F296A/Y375A and triple variant H191A/ 
F296A/Y375A slightly decreased to 45.2 and 46.6 °C, respectively (Table 5.4). The 
decrease in ΔHm was significant as the values for both variants were less 3 kJ.mol-1.  
5.3.7 Nitroreductase vs. ene-reductase functionality 
It has been previously postulated by Jensen, that enzyme evolution does not occur 
through conversion of one specific functionality to another, but, rather, from promiscuous 
enzymes as starting points for advancement.210 This concept has been further expanded 
by Khersonsky & Tawfik to define enzymes as ‘specialists’ and ‘generalists’, where 
‘specialists’ catalyze a specific reaction and ‘generalists’ are those that are 
promiscuous.211,212 Further, they discuss that directed evolution causes larger 
functionality trade-offs as the mutations commonly take place in the first shell (active 
site).212 Here, by mapping the ER and NR activities of KYE1, it can be seen that this is 
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indeed the case for this study; the ER ‘specialist’ is converted to a NR with a fairly strong 
negative trade-off (Figure 5.10). 
 
Figure 5.10 Evolutionary trade-off between ER and NR activity 
 
The reasoning behind the functional selectivity has been questioned and 
investigated to some extent by Oberdorfer et al. with glycerol trinitrate reductase (NerA) 
from Agrobacterium radiobacter as a model enzyme.213 However, in contrast to what was 
done in our study, the authors were focused on the comparison of aliphatic nitro 
reduction rather than aromatic. They compared NerA, OYE1, XenA and OPR-3 from 
Arabidopsis thaliana and attributed the difference in functionality, to the presence of a 
hydrophobic/hydrophilic patch in the binding pocket. Also, they discuss that the size and 
shape of the active site cavities have no clear relation with the functionality. However, as 
shown in their cavity representations, OYE1 has F297 and Y376 (equivalent to F296 and 
Y375 in KYE1) occupying a large amount of space (Figure 5.11). This observation leads 

























to the suggestion that the binding pocket size may indeed be important for aromatic nitro 
reduction functionality, but not aliphatic. 
 
 
Figure 5.11 Active sites of A) NerA, B) OPR-3, C) OYE-1, and D) XenA. The colored, 
semi-transparent surfaces each represent the shape of the associated enzyme’s active site 
cavity. The surfaces of the cavities are colored according to the 
hydrophobicity/hydrophilicity of the residues lining the active site (red hydrophobic, blue 
hydrophilic). The small insets in the lower left corners each show a cavity representation 
without the surrounding enzyme. Adapted from Oberdorfer et al.213 
 
5.3.8 Universal application of mutations 
Further studies were conducted to study whether these mutations could be universally 
applicable to other ERs with the expectance of a similar outcome. The equivalent 
residues of KYE1 H191, F296A and Y375 are H182, W276 and Y352 for YersER. The 
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combinations of YersER W276A/Y352A and H182/W276A/Y352A were created and 
studied for NR activity. However, these YersER variants did not yield the same results, 
indicating that the effect is not universal (data not shown).  
 
5.4 Conclusion 
In this work, a NR was successfully created from the ER KYE1 scaffold, through 
iterative site-directed mutagenesis based on rational design. With the hypothesis that 
increasing the binding site cavity volume would result in an increase of NR activity, we 
successfully created the variant F296A/Y375A. This enzyme showed to have more than a 
100-fold increase in specific NR activity and catalyzed the reduction of 4-NBS at 1.20 s-1. 
Further mutation of His 191 to Ala resulted in complete elimination of ER activity, but at 
the same time decreased the enzyme’s affinity towards NADPH. The created monomeric 
form of these NRs can be extremely useful for immobilization applications such as two-




6NAD(P)H OXIDASE V (NOXV) FROM LACTOBACILLUS 
PLANTARUM DISPLAYS ENHANCED OPERATIONAL STABILITY 
EVEN IN ABSENCE OF REDUCING AGENTS 
 
6.1  Introduction 
Enzymatic synthesis steps are used to produce active pharmaceutical ingredients (APIs) 
at higher yields, greater selectivity, and greater productivity than is possible through 
isolation of natural sources or chemically catalyzed routes. Interest in the nicotinamide 
cofactor aided production of rare sugars, namely L-nucleosides, for example L-ribose, L-
mannose and L-gulose, has arisen for a number of L-nucleoside-based pharmaceutical 
compounds, such as the hepatitis B drug Emtriva and the human immunodeficiency 
virus drug Clevudine. A number of such rare sugar-based pharmaceuticals are currently 
approved or in clinical trials.215 Another example of cofactor-assisted API synthesis is the 
production of keto acids, which are used to treat mild chronic renal insufficiency of 
hemodialysis patients and hyperphosphatemia.216,217 Thus, -ketoglutarate can be 
synthesized enzymatically from mono sodium L-glutamate (MSG) using L-glutamate 
dehydrogenase and a nicotinamide cofactor.143 
High costs of nicotinamide cofactors (NAD+: $30/g; NADP+: $230/g from 
laboratory suppliers) rule out the option of adding equimolar amounts for large-scale 
processes. A regeneration system is mandatory for advantageous economics but also 
often alleviates product inhibition, and acts as the driving force to overcome 
thermodynamic equilibrium limitations.144 Enzymatic, chemical, electrochemical, 
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photochemical, and biological methods have been proposed for cofactor 
regeneration.144,218,219 
 
Figure 6.1 Schematic conversion of ribitol to L-ribose through mannitol dehydrogenase 
from Apium graveolens complemented with NADH cofactor regeneration using nox2 
NADH oxidase. 
Among different systems that can be chosen for cofactor regeneration, NAD(P)H 
oxidases feature a number of benefits, as they utilize only NAD(P)H and oxygen as co-
substrates, both of which are available intracellularly (Figure 6.1) thus obviating 
exogenous addition, and, in the case of nox2 NAD(P)H oxidases, produce only water 
next to NAD(P)+.220 The reaction is carried out in a purely aqueous phase (in the absence 
of harsh solvents and metal catalysts).  
The NoxV gene codes for an annotated NADH oxidase (NoxV) from 
Lactobacillus plantarum consisting of 1350 bp with a predicted size of 49 kDa. This 
study investigates the enzymatic properties of NoxV. A higher enzymatic productivity is 
achieved compared to its analogs, as evidenced by NoxV’s higher TTN and increased 
stability against over-oxidation. Furthermore, while the wildtype enzyme solely accepts 
NADH as a substrate, we engineered the substrate binding pocket so that the enzyme also 



















6.2 Materials & Methods 
6.2.1 Enzymes and other materials 
The gene of NADH oxidase V (NoxV) from Lactobacillus plantarum 10S was obtained 
via gene probe from genomic DNA from the American Type Culture Collection 
(Manassas, VA), ATCC 10012. NADH and NADPH were obtained from Amresco 
(Solon, OH) and EMD chemicals (Gibbstown, NJ), respectively. MagicMediaTM 
Escherichia coli Expression Medium was purchased from Invitrogen (Carlsbad, CA). 
Molecular biology reagents such as dithiothreitol (DTT) were obtained from JT Baker 
(Phillipsburg, NJ), all other materials such as various salts used for buffers, β-
mercaptoethanol (BME) and NAD+ were obtained from Sigma-Aldrich (St. Louis, MO). 
Oligonucleotides for cloning were purchased from Eurofins-MWG|Operon Biosciences 
(Huntsville, AL).  
6.2.2 Cloning 
The gene was cloned through PCR using the primers in Table C.2 The PCR product was 
gel purified with a Qiagen gel extraction kit and cloned into a pET-28a vector (Novagen; 
Darmstadt, Germany). The plasmid was then transformed into E. coli BL21(DE3)pLysS 
for expression. Constructs were confirmed with sequencing through Eurofins-
MWG|Operon Biosciences (Huntsville, AL).  
6.2.3 Site-directed mutagenesis  
Single and double mutations were performed on residues G178 and L179 into K, R and 
K, R, H respectively, through overlap and Quikchange® PCR protocol using the primers 
in. Degenerate codons were used to generate multiple mutants with single 
transformations. ARR codes for amino acids R and K, and CRY codes H and R. The 
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DNA from PCR was transformed into E. coli XL1-blue. Colonies were picked from agar 
plates and sent for sequencing to Eurofins-MWG|Operon Biosciences (Huntsville, AL).  
6.2.4 Overexpression 
Growth and overexpression was carried out in MagicMediaTM E. coli Expression Medium 
(Invitrogen; Carlsbad, CA) with a final concentration of 30 g.mL-1 each of kanamycin 
and chloramphenicol. A dual temperature protocol was used for growth, starting out at 30 
°C for 6 h, and then continued at room temperature (25±2 °C) for an additional 22 h. 
Cultures were harvested by centrifugation in a Beckman centrifuge at 4,050 g for 20 min 
in 50 mL conical tubes. The resulting cell pellet was either frozen, and stored at -80 °C or 
purified directly as described below. 
6.2.5 Purification 
Purification of NoxV was carried out at 4 °C or on ice to prevent denaturation of the 
enzyme. Cell pellets were resuspended in 15mL of 10 mM Tris-Cl buffer, pH 7.5 with 5 
mM DTT (Buffer A) and sonicated at 14 W for 30 s nine times. Sonicated cells were 
centrifuged at 18,500 g for 30 min. The clarified cell lysate was then dialyzed against 250 
mL of buffer A with 50% ammonium sulfate for 2 h. The dialysis membrane was 
transferred to fresh buffer and further dialyzed for 2 h. The solution was then centrifuged 
at 18,500 g for 30 min. The resulting supernatant was filtered through a 0.8 m and 0.2 
m microfiltration membranes in series. The filtrate was loaded onto a HiPrep 16/10 
butyl hydrophobic interaction column on an ÄKTAexplorer™. A gradient separation was 
performed starting from buffer A with 30% ammonium sulfate to 15%. The fractions 
with the highest activity were collected and dialyzed against buffer A for 2 h. After 
exchanging to fresh buffer the sample was dialyzed for an additional 2 h. The sample was 
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loaded on a HiPrep 16/10 DEAE weak anionic exchange column on the 
ÄKTAexplorer™. Separation was achieved with buffer A containing NaCl, a gradient of 
150 to 250 mM. The resulting fractions were assayed and the ones with highest activity 
were collected as pure protein. The purified protein was either stored in 4 °C or in -20 °C 
with 25% glycerol. 
6.2.6 Enzyme assay and protein determination 
Standard assays to detect enzymatic activity were performed in 100 mM Triethanolamine 
(TEA) buffer pH 7.5 with 5 mM DTT in cuvettes with either 1 cm or 1 mm path length, 
depending on the concentration of substrate. Excluding studies of enzymatic activity and 
stability temperature dependence, all activity assays were performed with samples that 
were either pre-equilibrated to 25 °C, using a thermomixer (Eppendorf; Hamburg, 
Germany) or made and used directly at room temperature. Initial activity was measured 
by following the absorbance change using a Beckman Coulter DU 800 UV/Vis 
spectrophotometer at 340 nm. Activity of the enzyme was calculated using an extinction 
coefficient, ε, of NAD(P)H as 6,220 M-1.cm-1.221 Unless otherwise noted, a substrate 
concentration of 0.2 mM NAD(P)H and enzyme concentration of 4 nM was used for 
assays. One unit (U) of activity is defined as µmol of NAD(P)+ produced per minute. 
The protein concentration was estimated by a Bradford assay.163 BSA was used as 
standards and the absorbance was measured on a biophotometer (Eppendorf; Hamburg, 
Germany). SDS-PAGE analysis was performed to confirm the purity. 
6.2.7 pH activity 
Enzyme pH activity profiles were obtained at 25 °C using 100 mM buffers containing 
one of the following salts: sodium citrate from pH 4.0 to pH 6.5; sodium phosphate from 
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pH 6.0 to pH 8.0; TEA from pH 7.0 to pH 8.0; Tris-Cl from pH 7.0 to pH 9.0; glycine 
from pH 9.0 to pH 10.0.  
6.2.8 Temperature activity 
The dependence of the enzymatic activity on temperature was studied by preheating the 
buffer to different temperatures, and then adding the enzyme. After 1 min of incubation, 
the standard assay was carried out. A temperature range of 10 to 55 °C was chosen for 
this study. 
6.2.9 Temperature stability 
Temperature stability was studied by incubating the enzyme at various temperatures for 
30 min. The enzyme solution was then cooled down and assayed at 25 °C. This study 
covered a range of 15 to 55 °C. 
6.2.10 Kinetic parameters 
Depending on the enzyme, a substrate concentration range from 1.5 µM up to 984 µM 
was investigated to determine the kcat and Km values for NAD(P)H. This was conducted at 
atmospheric concentrations of oxygen, 0.25 mM, present in the system. Doubly 
concentrated solutions were prepared by adding each the substrate and enzyme to 100 
mM TEA buffer pH 7.5. The reaction was initiated by mixing the two solutions. The 
specific activity was measured, and the kinetic parameters were calculated from that data. 
Inhibition effects were measured by incubating the enzyme with NAD+ for 30 minutes 
before the assay. A range of 0.2, 0.3, 0.4 and 0.6 mM were chosen and investigated. 
6.2.11 Amplex Red Assay (H2O2 presence) 
An Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Invitrogen; Carlsbad, CA) 
was used to determine the amount of hydrogen peroxide (H2O2) produced during 
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turnover. The presence of H2O2 was determined by incubating the standard assay mixture 
with Amplex Red and peroxidase. Produced resorufin is detected with an extinction 
coefficient, , of 54,000 M-1.cm-1 via fluorescence spectroscopy with maximal emission 
at 587 nm and indicates H2O2 production with strict 1:1 stoichiometry. Various amounts 
of substrates were reacted and assayed to detect the presence of H2O2. The reactions were 
carried out in the provided 50 mM sodium phosphate buffer pH 7.4. Standards for the 
calibration curve were prepared with the same reaction buffer. Steady-state emission and 
excitation spectra were recorded with a PTI fluorimeter (Birmingham, NJ). 
6.2.12 Total turnover number (TTN) 
Standard kinetic assays at pH 7.5 and 25 °C in air-saturated solution were performed with 
0.25, 0.5 and 1.0 nM of enzyme. 0.2 mM NAD(P)H substrate concentration was used. 
Assays were carried out for 2 to 3 h until there was no more enzymatic conversion of the 
substrate. Calculations of TTN were performed by dividing the change of NAD(P)H 
concentration until activity reached a standstill by the (necessarily very low) 
concentration of enzyme subunits that was used for each assay. As the stock solution of 
enzyme contained DTT, the buffer was exchanged to 10 mM Tris-Cl pH 7.5. 
 
6.3 Results & Discussion 
6.3.1 Cloning, expression, and purification 
NoxV was identified through a sequence blast search. It has high similarity and identity 
levels with many other water-forming NADH oxidases (Table 6.1). The NoxV gene was 
cloned from genomic DNA of ATCC 10012 and inserted into a pET-28a vector using 
restriction sites NcoI and XhoI. Sequencing results of the gene showed a missense 
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mutation where the nucleotide at position 45 changed from C to T (accession number: 
Q88SH4). 
NoxV was overexpressed in E. coli BL21(DE3)pLysS constituting 8% of cell 
protein. Purification of NoxV resulted in a yield of 14% of the total units and a 12.7-fold 
increase of specific activity to 167.5 U.mg-1 (Table 6.2). The pure protein was identified 
as a single band at 49 kDa in sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) analysis (lane 5, Figure 6.2). 
 
 
Figure 6.2 SDS-PAGE (12% gel) analysis of NoxV. Lane 1: 15 µg lysate, Lane 2-3: 6 
and 3 µg, respectively, of dialyzed protein collected from HiPrep 16/10 Butyl column, 
Lane 4-5: 3 and 1 µg, respectively, of collected protein from HiPrep 16/10 DEAE column. 




Table 6.1 Sequence identity and similarity comparison of water forming NADH oxidases 









Lactobacillus sanfranciscensis 59.4 72.2 Q9F1X5 [128] 
Lactococcus lactis  33.1 56.1 A2RIB7 [134] 
Lactobacillus brevis  64.0 74.2 Q8KRG4 [133] 
Enterococcus faecalis  33.0 42.9 P37061 [132] 
Streptococcus mutans  9.4 19.8 Q54453 [131] 
 
 
Table 6.2 Table of purification. Lysate: clarified lysate; AS50 dia.: supernatant from 
centrifuged sample dialyzed against 50% ammonium sulfate; Butyl dia.: fractions 
collected from HiPrep 16/10 Butyl column dialyzed against 100 mM TEA pH 7.5 and 5 















Lysate 20 1843.5 139.3 13.2 1.0 100 
AS50 dia. 7 930.0 88.5  10.5 0.8 50 
Butyl dia. 37.5 379.3 4.7 80.7 6.1 21 
DEAE 20 261.9 1.6 167.5 12.7 14 
 
6.3.2 Enzyme activity and stability 
NAD(P)H oxidases are used exclusively in cofactor regeneration because their 
byproducts, water and hydrogen peroxide, are not of interest. As utility of NADH 
oxidases can only be derived through coupling with other enzymes, their operating 
conditions must be able to match those of the cofactor consuming enzyme. Consequently, 
studies of reaction conditions, especially in terms of pH value and temperature, are 




Figure 6.3 L. plantarum NoxV activity profile in different buffers (100 mM) at different 
pH values at 25 °C. 
 
NoxV showed a rather broad pH activity range. Maximum activity was found at 
pH 7.5, independent of buffer type. The enzyme’s optimal activity range was from pH 5.5 
to 8.0, a common range for NAD(P)H oxidases (Figure 6.3). The upper limit is 
compatible with most dehydrogenases, so appropriate coupling seems feasible. 
 






























Figure 6.4 L. plantarum NoxV activity profile at various temperatures with 100 mM 
TEA buffer pH 7.5. 
 
 
Figure 6.5 T  plot to study stability of L. plantarum NoxV by incubating at different 
temperatures for 30 min each. 
 







































The temperature activity profile showed that maximum instantaneous activity was 
found at 40 °C, and the activity quickly declined to zero beyond that temperature (Figure 
6.4). Using an Arrhenius model and data between 10 and 38 °C, the activation energy Ea 
was calculated as 32.7 kJ.mol-1, and the deactivation energy (40-55 °C) Ed was calculated 
as -93.6 kJ.mol-1. The temperature that exhibited half of the original activity after 30 
minutes, T5030, was estimated to be 45 °C (Figure 6.5). At 55 °C the enzyme was 
completely inactive. The enthalpy of deactivation, Hd, was calculated using the van't 
Hoff equation to be 5.0 kJ.mol-1 (Figure 6.5).  
6.3.3 Kinetic parameters  
Apparent kinetic data were obtained at constant oxygen concentration (air saturation) at 
25 °C and pH 7.5 over a concentration range of NADH from 5 to 200 µM. The data were 
fitted with four different models (non-linear Michaelis-Menten, Lineweaver-Burk, Eadie-
Hofstee, and Hanes-Woolf), all of which were in good agreement. Through non-linear 
fitting with a least squares approximation, the apparent  and  values of the 





Figure 6.6 Nonlinear fitting to a Michaelis-Menten kinetic to determine the kinetic 
parameters   and Km at pH 7.5, 25 °C. 
 
 
Figure 6.7 Hanes-Woolf plot to identify NAD+ inhibition. 
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Possible product inhibition was investigated by incubating the enzyme with 
different concentrations of NAD+. A non-competitive inhibition pattern was observed 
where the vmax value decreased with increasing inhibitor concentration, while 
 was constant. The product inhibition constant,  was calculated to be 
289 µM for NAD+ (Figure 6.7). The apparent inhibition ratio /  is 
calculated to be 0.17. As this ratio is less than unity, it indicates that complete conversion 
is possible despite the non-competitive product inhibition.222 
6.3.4 Water/H2O2 formation 
The Amplex Red assay was performed to determine whether NoxV is a water- or 
hydrogen peroxide-producing enzyme. H2O2 was formed in 2.63% of the catalytic events, 
slightly higher than the analogs from Lactobacillus sanfranciscensis (0.2%) and 
Lactococcus lactis (0.4-0.7%), thus strongly suggesting that NoxV is a water-forming 
oxidase.128,134 
6.3.5 Total turnover number (TTN) 
Total turnover number (TTN) is a measure of catalyst productivity, defined as the total 
amount of product produced over the lifetime of an enzyme.5 The TTN, in presence of 




Figure 6.8 Total turnover number (TTN) analysis with different amounts of enzyme. The 
reaction was carried on until there was no consumption of substrate. ([E] = 0.25, 0.5 and 
1.0 nM, 25 °C, pH 7.4) 
 
Three potential causes of TTN limitation, which are commonly associated with 
enzyme deactivation, were investigated: i) thermal deactivation at 25 °C, ii) deactivation 
caused by H2O2, and iii) non-competitive product (NAD+) inhibition in the system. 
Thermal stability at 25 °C (i) was measured by incubating the enzyme for extended 
periods of time. The enzyme was then assayed to determine the remaining activity. As 
there was no enzymatic activity loss after two hours (data not shown), which is longer 
than the reaction completion timescale (Figure 6.8), this study proved that the enzyme 
became catalytically inactive before it began to thermally deactivate. The effect of H2O2 
was studied (ii) at 25 °C and pH 7.5 within a concentration range from 25 to 200 µM. 
Even at high concentrations of H2O2 the specific activity did not change over one hour 
(data not shown), thus demonstrating that the enzyme is indeed stable against H2O2. The 























presence of NAD+ inhibition (iii) and its pattern had been elucidated (Figure 6.7). 
However, as expected from the apparent inhibition ratio of 0.17, even at high 
concentrations of NAD+ there was a reasonable amount of residual activity (data not 
shown), so it cannot be concluded that NAD+ had inhibited the reaction completely. The 
cause of TTN-coupled deactivation is still not fully elucidated but it is not related to 
temperature nor either H2O2 or NAD+ concentration.  
 
Table 6.3 Comparison of TTN with and without DTT, for NADH oxidases from L. 
plantarum, L.sanfranciscensis, and L. lactis.  
  NADH  NADPH 
Organism Enzyme TTN TTN with 
DTT 
 TTN TTN with 
DTT 
L. plantarum NoxV WT 128,000 168,000  - - 
 L179R 181,000 148,000    
 G178R/L179R 123,000 162,000  100,000 107,000
L. 
sanfranciscensis143 
Nox2 5,000 112,500    
L. lactis134 Nox2 38,740 78,480  - - 
For all the TTN measurements the relative standard deviation (%RSD) was less than 5%, 
except for the TTN of mutant G178R/L179R with NADH, which was 12%. 
 
To investigate the effect of reducing agents on the TTN, measurements were 
taken with and without reducing agents. The TTN without reducing agents, with 5 mM 
DTT, and with 5 mM BME were 128,000, 168,000, and 107,000 respectively. The 
presence of DTT had a positive effect but it was not as dramatic compared to the NADH 
oxidase from L. sanfranciscensis, which has an increase of over 20-fold.143 However, 
addition of BME decreased the TTN by ~15%. The reason for the different influence of 
the reducing agents on the TTN is unknown, and will be assessed in future studies. One 
intriguing but speculative thought focuses on the different stoichiometry of the sulfenic 
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acid reduction for DTT and BME: a single molecule of DTT is capable of performing 
reduction, whereas two molecules of BME are required. In contrast, the first molecule of 
BME initiates thiol-disulfide interchange and occupies the water channel, thus blocking 
access to the second BME molecule and leaving the residue inactive.  
NoxV has shown a higher TTN compared to previously studied NADH oxidases 
from L. sanfranciscensis and L. lactis, both with and without exogenously added 
reducing agents (Table 6.3). Such a higher TTN is an indication of improved intrinsic 
stability against overoxidation at the catalytically active cysteine residue because DTT, a 
known enhancer of TTN in the other NADH oxidases from L. sanfranciscensis and L. 
lactis, has little effect on the TTN in L. plantarum. As overoxidation of a catalytic 
cysteine is known as limiting catalysis over time in enzymes such as D-amino acid 
oxidase from Trigonopsis variabilis and xenobiotic reductase A (Xen A) from 
Pseudomonas putida, this increased intrinsic stability is of great interest.203,223 The reason 
of decreased influence of reducing agents will be addressed in future works. Studying the 
exposure of the active cysteine in different enzymes would be of most interest to see if i) 
it is less accessible to the reducing agents or ii) protected from possible overoxidation 
factors, such as oxygen and H2O2. 
The increased stability without reducing agents would be favorable since there are 
known inhibition effects of DTT on certain rare sugar- producing dehydrogenases, such 
as mannitol dehydrogenase from Apium graveolens.224 Also, improved stability without 
reducing agents would be a significant advantage in industries where the use of reducing 




6.3.6 Mutation for NADPH activity 
Wild type NoxV had activity exclusively towards NADH and not towards NADPH. To 
introduce NADPH activity, substrate binding pocket mutations were carried out. 
Homology modeling of the sequence of NoxV from L. plantarum onto the crystal 
structure of NAD(P)H oxidase from L. sanfranciscensis revealed electrostatic differences 
in the substrate binding pocket.130 Nox2 from L. sanfranciscensis features histidine (His 
181) to enable the negative charge accommodation of the NADPH 2′-phosphate, but 
NoxV consists of only small or hydrophobic residues in that area. Based on this 
knowledge, these residues were targeted for mutation with basic residues such as 
histidine, lysine and arginine.225-227 
The single mutations of residues G178 and L179 into K, R and K, R, H, 
respectively, and double mutations 178/179 were performed and investigated for 
substrate specificity. The mutation of G178H was excluded because then two histidines 
would be positioned next to each other, causing steric hindrance within the binding 
pocket. The resulting mutants were expressed on small scale and assayed at the cell lysate 
level (Table 6.4). All the mutants showed activity with both NADH and NADPH as 
substrates. Among the single and double variants, L179R shows the highest specific 
activity at 25 °C and pH 7.5 with NADH (7.32 U.mg-1) and G178R/L179R with NADPH 
(6.00 U.mg-1), compared to wild-type at 10.0 U.mg-1. We surmise that introduction of an 
additional positive charge at G178R stabilizes the positioning of L179R, decreasing the 
ability of free rotation of L179R side-chain bonds through hydrogen bonding. Arginine 
may be expected to provide the greatest NADPH activity because it has the most 
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positions for hydrogen bonding. The low activity of L179H can be rationalized by the 
presence of an adjacent proline causing steric hindrance. 
Table 6.4 Cell lysate activity of mutants. 
Mutant NADH activity (U.mg-1) NADPH activity (U.mg-1)
Wild Type 10.0 0.00 
G178K 3.92 0.46 
G178R 1.51 0.23 
L179K 5.14 1.03 
L179R 7.32 1.76 
L179H 1.37 0.64 
G178K/L179K 0.84 3.11 
G178K/L179R 2.00 5.68 
G178K/L179H 1.24 3.85 
G178R/L179K 0.94 3.56 
G178R/L179R 2.64 6.00 
G178R/L179H 0.64 0.52 
 
6.3.7 Study of variants L179R and G178R/L179R 
L179R and G178R/L179R were selected for further purification and kinetic 
characterization (Table 6.5), and showed an FAD/enzyme ratio of 1.42 and 0.71, 
respectively (data not shown). The difference in flavin content seems to be due to spectral 
absorbance error from the low enzyme concentrations, and the FAD/enzyme ratio would 
most likely be close to one, which would be comparable to previous NOXs.130 L179R 
was not as active as the wild-type (lower ). However, the  value was also 
much lower, improving the specificity /  more than 4-fold. The mutant 
also showed NADPH activity but with a very high value. The double mutant 
G178R/L179R shows a trend similar to L179R: decreased  and  
values, resulting in an improved specificity kcat,app/Km,NADH of 13.2 µM-1.s-1. For NADPH 
activity /  was 11.7 µM-1.s-1. Overall, both variants yielded improved 
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specificities /  for both NADH and NADPH. The TTN of the two variants 
behaved similarly to the wild-type, in that the presence of reducing agents did not affect 
the processing stability (TTN) to a great extent (Table 6.3). 
  
Table 6.5 Kinetic parameters of wild-type (WT) and mutant NAD(P)H oxidases. Data 
were fitted with least squares approximation to Michaelis-Menten kinetics with an R2 of 
0.96 or higher. 
Enzyme NADH  NADPH 










WT 211.6 50.2 4.22  - - - 
L179R 122.0 6.56 18.6  146.4 489.6 0.30 
G178R/L179R 34.0 2.57 13.2  114.1 9.76 11.7 
 
6.4 Conclusion 
Starting from an annotated sequence, NADH oxidase V from L. plantarum (ATCC 
10012) was developed and demonstrated to be a very active enzyme in air-saturated 
aqueous buffer at pH 7.5 and 25 °C ( ,  = 212 s
-1 and  = 50.2 µM). The 
temperature and pH optima, 45 °C and pH 5.5-8.0, respectively, overlap with relevant 
dehydrogenases that might be coupled for cofactor regeneration with NoxV. With total 
turnover numbers (TTN) of 128,000 and 168,000, respectively, in the absence and 
presence of DTT, L. plantarum NoxV demonstrated high processing stability regardless 
of the presence of reducing agents, a first among NADH oxidases. 
After inspection of the homology model of L. plantarum NoxV on the structure of 
the L. sanfranciscensis analog, mutations in the substrate binding pocket to basic amino 
acid residues to accommodate the negative charge of the 2′-phosphate of NADPH were 
introduced to broaden the substrate specificity to NADPH. All single and double variants 
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G178K,R/L179K,R,H exhibited significant NADPH and NADH activity. Novel and 
more stable cofactor regeneration enzymes, in conjunction with novel methods of 
immobilization, such as on functionalized nanotubes , stand to further broaden the 






7RECOMMENDATIONS AND CONCLUSIONS 
 
7.1 Recommendations 
7.1.1 Enzymatic reduction of hydroxylamine 
As shown in Chapter 2, nitroreductases (NRs) are capable of producing hydroxylamine, 
but not the amine. The exact reason why NRs do not reduce the –NHOH is unknown has 
yet to be determined. To complete the biocatalytic reduction from hydroxylamino to 
amino there two approaches can be proposed: engineering the current NR and altering its 
selectivity to produce amines or utilizing a different enzyme system that is capable of 
reducing hydroxylamimes and pairing it with NRs. 
For NR engineering two possibilities can be proposed to overcome the lack of 
amine production. The first proposition is to engineer a NR to alter the redox potential of 
the bound flavin. Previously, Koder et al. has suggested that the last reduction step is 
improbable due to limitations in the flavin redox potential compared to the substrate.40,229 
Our collaborator Dr. Anne-Frances Miller’s group at the University of Kentucky will 
investigate the possibility of lowering the flavin redox potential by changing the enzyme 






Figure 7.1 Comparison of nitro, nitroso, hydroxylamine moieties. 
 
 
Figure 7.2 Crystal structure of NRentcl (PDB ID: IKQB) highlighted with FMN (yellow) 
and benzoate inhibitor (orange) and residues within 4 Å of benzoate at the dimer interface 
(monomers represented in blue and silver). Image rendered with Visual molecular 
dynamics (VMD).41  
 
The second proposal is to modify the hydrogen bonding characteristics in the 
enzyme. Both nitro- and nitrosobenzene have several hydrogen bond acceptors, whereas 
hydroxylamines have hydrogen bond donors (Figure 7.1). These different characteristics 
could govern whether or not the substrate will bind for catalysis. As there is no reduced 
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NR crystal structure available with a bound inhibitor the oxidized form with benzoate 
bound as an inhibitor was studied for possible mutation sites. Mapping the active site 
with residues within 4 Å of benzoate yielded four amino acids as mutational candidates 
which were S40, T41, F124, and E165. Among these four, S40 and T41 should be 
investigated first as they are hydrogen bond donors in close proximity to the carboxyl 
group of benzoate. Steric considerations indicate that the best residues to replace these 
are glycine, alanine and valine. However, as the exact mechanism of interaction is 
unknown, directed evolution in combination with site-saturation mutagenesis may be 
beneficial. 
An alternative biocatlytic route can also be considered for the final reduction step 
from hydroxylamine to amine. The use of a NADH cytochrome b5 reductase (CYB5R) 
and cytochrome b5 (CYB5) enzyme system has been published in the context of 
microsomal reduction of hydroxylamines in humans. Kurian et al. were able to show the 
substrates sulfamethoxazole hydroxylamine and dapsone hydroxylamine to their 
corresponding amines.230 Catalysis is proposed to occur through the transfer of electrons 
from NADH to CYB5R (two-electrons), from CYB5R to CYB5 (one-electron), and from 
CYB5 to the hydroxylamine. As both NRs and CYB5R utilizes NADH as the electron 
donor there will be no need for an additional cofactor regeneration system. Therefore, the 
complete reaction can be conducted as a one-pot synthesis (Figure 7.3). This work will be 





Figure 7.3 Proposed reaction scheme with a conjugated system of NRs and cytochrome 
enzymes (CYB5R and CYB5). Reduction of nitroaromatics (Ar-NO2) to hydroxylamines 
(Ar-NHOH) are catalyzed with NRs and the subsequent reduction to amines (Ar-NH2) is 
catalyzed by the cytochrome enzyme system. 
 
7.1.2 High-throughput colorimetric assay 
When generating a large number of enzyme variants through directed evolution (Section 
7.1.1), it is necessary to have a quick and effective method to qualitatively analyze the 
occurring changes. As the goal is to alter the selectivity towards amine, the current assay 
that monitors the oxidation of NAD(P)H and relates that to substrate reduction is 
inadequate. The general rule of directed evolution is that “you get what you screen for” 
231, thus, selecting variants based upon increased NAD(P)H oxidation rates will not 
necessarily translate into change in selectivity.  
There are several fluorimetric and colorimetric assays that have been previously 
developed for the detection of amines including ninhydrin232, fluorescamine233, o-
phthalaldehyde234. However, these assays cannot be utilized in biocatalytic assays due to 
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their affinity to the enzyme in the reaction solution. Further, many of these reagents react 
with the different redox states of nitrogen making it difficult to selectively quantify the 




Figure 7.4 MBTH assay results. a) spectrum of the different redox states coupled with 
MBTH and b) color observed from 2 M substrate. 
 
Pentacyanoammineferroate sodium salt (PCAF) and 3-methyl-2-
benzothiazolinone hydrazone hydrochloride monohydrate (MBTH) were identified as 
candidates for the development of a colorimetric aromatic amine selective assay. PCAF 
























exhibited a fairly high extinction when reacted with aniline, but showed better affinity 
towards the PHA (data not shown). MBTH, which was initially developed as a phenol 
detection assay 235, selectively reacts with aniline under acidic conditions to produce a 
bright magenta color (Figure 7.4, for reaction details see Appendix F). Notably, NOB 
has a very strong signal that arises when associated with MBTH. This is problematic 
because over time the color even shifts towards the amine signal, making it difficult to 
resolve the two. One method to alleviate this problem is to conduct all experiments in 
anaerobic conditions. This has been tested and confirmed to work by one of our 
collaborators, John Hoben at the University of Kentucky. This will further eliminate the 
oxidation problems that are associated in the dual presence of hydroxylamines and 
molecular oxygen. Additionaly, color formation was also observed with Tris buffer 
which is an amine salt. Further work must be performed to investigate whether the 
selectivity holds in different reaction conditions, especially in the presence of cell lystate. 
If cell lystate proves to be detrimental a partial his-tag purification can be performed on 
nickel coated 96-plate well plates.  
7.1.3 Overcoming low solubility 
One of the major barriers that need to be addressed is the low solubility of many of the 
nitro aromatic substrates. The limitations in solubility are extreme to the extent that some 
substituted nitrobenzenes can only be dissolved up to 0.1 (w/w) % in aqueous solutions. 
Even with the enzymo-chemical synthesis developed in Chapter 4, the major bottleneck 
in synthesis is tied to low solubility. 
To overcome this hurdle, the enzymo-chemical synthesis can be run in a 
continuous two-pot, two-step fashion. The hydroxylamine reduction step could then be 
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carried out in either a purely-aqueous or an aqueous-organic solvent. Although the 
concept of a two-pot, two-step system is straight-forward, it is unknown whether the 
reduction to amine with FSA will happen at similar levels. Another alternative can still be 
to run a one-pot, two-step system with the addition of organic solvents to increase the 
solubility or availability of substrates. For this system, possibilities include the use of 
both mono- and bi-phasic systems. However, to properly apply this technique, enzymes 
will either need to have high stability in solvents (monophasic option) or avoid contact 
with it (biphasic option). As flavoenzymes require the use of nicotinamide cofactors and 
a paired regeneration system, it will be difficult to perform reactions in solely organic 
solvents. High stability of enzymes in the presence of organic solvents can be attained by 
enzyme immobilization. Immobilization can be achieved through methods such as 
support binding, entrapment and cross-linking.236 One concern that can arise for 
immobilization is the fact that NRs have its active site at the dimer interface. Depending 
on the immobilization method, the force could potentially make the monomers dissociate. 
To overcome such a problem, a monomeric NR, such as that developed in Chapter 5, 
could be used for immobilization. 
 
7.2 Conclusions 
The use of biocatalysis for synthesizing valuable molecules is an area where still much 
research can be done. This holds true for the application of nitroreductases (NRs) as well. 
Given the vast amount of known NRs and literature published on them, it is quite 
astonishing that there are still questions regarding their mechanism and product 
distribution. Although the goal of this thesis was not focused on identifying these aspects 
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the results obtained from Chapter 2 and 3 help understand these characteristics. Through 
the use of analytical tools, such as 15N-NMR and HPLC, we were able to show that the 
enzymatic product from NB was PHA, not AN. Further, the reason for amine formation 
that is observed in limited examples was investigated to define whether this phenomenon 
is dependent on the enzyme and/or substrate. Comparison of the product spectrum of 
NRsalty and NRmycsm suggested that the selectivity is most likely related to the 
substrate features such as aromaticity and electron effects. Details on the nitro reduction 
mechanism were obtained while comparing these two enzymes and their pH 
dependencies. The transition in log	 ⁄ / ⁄   that NRmycsm exhibits, 
leads us to propose that enzyme is being heavily influenced by substrate binding or 
transition state stabilization depending on the substituent. Additional experiments to 
study the substrate binding kinetics have been proposed to obtain more insight on this 
matter. Most importantly, through the Hammett correlation we were able to develop a 
quantitative structure–activity relationship (QSAR) that indicates that substrates with 
more electron-withdrawing groups will be the best candidates for biocatalytical 
reduction.  
 As the desired amine was not produced through NRs, an attempt to further reduce 
the hydroxylamine was made. The first approach was through the establishment of an 
enzymo-chemical synthesis where NRs were paired with FSA to create a one-pot two-
step synthesis. With the addition of the acidic reduction step we were able to obtain a 
90.2% yield of 4-aminobenzoic acid starting from 4-nitrobenzoic acid. The second 
approach was to develop a high-throughput colorimetric assay to aid the alteration in 
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substrate specificity via directed evolution of NRs. An assay utilizing MBTH was 
developed but is still in the preliminary stages of application. 
For the purpose of expanding the immobilization application possibilities, NRs 
were successfully created from monomeric ER KYE1 scaffolds. The best variant 
F296A/Y375A showed to have more than a 100-fold increase in specific NR activity and 
was able to catalyze the reduction of 4-NBS at 1.20 s-1. Another variant 
H191A/F296A/Y375A had no reactivity towards KIP while maintaining comparable NR 
activity to the double variant 
A different type of enzyme, NADH oxidase V (NoxV) from Lactobacillus 
plantarum, was characterized and developed for nicotinamide cofactor regeneration. This 
enzyme demonstrated to not only be very active ( ,  = 212 s
-1 and  = 50.2 
µM), but it showed to have a superior TTN compared to other Noxs, especially in the 
absence of reducing agents (TTN = 128,000). This high processing stability regardless of 
the presence of reducing agents is a first among NADH oxidases. Further, protein 
engineering was performed to alter the substrate specificity and accommodate NADPH. 
The variants L179R and G178R/L179R exhibited significant NADPH and NADH 
oxidase activity and maintained high TTN.  
This dissertation investigated a number of flavoenzyme applications for active 
pharmaceutical ingredient (API) production. In some cases it was through direct 
participation in the reaction of interest, whereas in other cases it was by fulfilling a 
supporting role. Regardless of the function, the value in the target molecules and the 






The use of enzyme nomenclature can show inconsistencies in many cases. This is also the 
case for nitroreductase names. Below are some examples.  
A.1 The gene is called both by nfnA (nfsA) and nfnB (nfsB), and the enzyme as 
NfsA, NfsB or NTR.162 
A.2 The nitroreductase from E. cloacae is known as NR, which here is the 
universal nomenclature for Nitroreductase.40 
A.3 Change in name due to change in publishing group. “Classical” 
nitroreductase (Cnr) and NRSal are identical enzymes.39,237 
A.4 GlNR1 from Giardia lamblia is deposited in Genbank as Fd-NR2.238 
To avoid these complications, in this document we propose a systematic nomenclature 
for naming nitroreductases, where all NRs shall be named in conjunction to their species 
name. For example, a NR from Escherichia coli will be named with the first three letters 
of the first word and two letters of the second word, NRescco. The use of multiple 
characters is necessary as it will be impossible to distinguish E. coli and Enterobacter 
cloacae if they are abbreviated as “ec”. Again, this is for convenience and clarity of this 
thesis. To avoid confusion, the enzymes will be documented in their original names in the 











Figure B.1 NR phylogenetic tree created with Maximum Likelihood (ML) method with a  













Figure B.2 ER phylogenetic tree created with Maximum Likelihood (ML) method with a  



























OYE1 - 80.5 45.4 47.7 34.3 15.3 14.3 17.2 18.0 
KYE1 71.5 - 47.0 46.8 32.8 17.8 15.6 18.8 17.3 
PETN 34.3 35.8 - 83.0 37.7 18.1 18.4 18.6 21.0 
YersER 36.0 34.3 74.5 - 38.3 19.4 20.2 19.9 21.3 
XenA 22.4 22.3 24.6 24.2 - 19.0 19.0 17.9 22.0 
NRsatly 9.3 10.3 11.5 12.4 10.5 - 92.2 90.8 30.4 
NRentcl 8.0 10.3 11.0 11.5 9.6 88.9 - 90.3 30.4 
NRescco 9.7 12.0 11.5 12.4 11.6 88.5 88.0 - 29.1 







CONSTRUCTS & PRIMERS 
 
Table C.1 Construct information 
Enzyme  Organism Accession
Number 
Vector Restriction sites Tags 
NRsalty S. typhimurium P15888 pET-28a NcoI/XhoI none 
NRentcl E. cloacae Q01234 pET-24d NcoI/XhoI none 
NRentcl-TRX E. cloacae Q01234 pET-32a NcoI/XhoI TRX, TEV, N-His
NRentcl-his E. cloacae Q01234 pET-28a NdeI/XhoI N-His 
NRmycsm M. smegmatis A0R6D0 pET-28a NdeI/XhoI N-His, C-His 
XenA P. Putida Q9R9V9 pET-27b NdeI/HindIII none 
KYE1 K. lactis P40952 pET-28a NdeI/XhoI N-His, TEV 
YersER Y. bercovieri C4RW35 pET-28a NdeI/HindIII N-His 




Table C.2 Primer design for NoxV variants. Mutated residues are colored gray and the 
affected codons are underlined  



























Table C.3 ER to NR site-directed mutagenesis primer forward sequence. Mutated 
residues are colored gray and the affected codon is underlined 










































Table C.4 Primer design for NRentcl library Mutated residues are colored gray and the 
affected codon is underlined 
Enzyme Mutatation Sequence (5′ to 3′) 
NRentcl T41N GCAGTACAGCCCGTCCAGCAACAACTCCCAGCCGTGGCA 
 T41Q GCAGTACAGCCCGTCCAGCCAGAACTCCCAGCCGTGGCACT 
 S40NNK GCTGCAGTACAGCCCGTCCNNKACCAACTCCCAGCCGTGG 
 T41NNK GCAGTACAGCCCGTCCAGCNNKAACTCCCAGCCGTGGCACT 
 T41S GTACAGCCCGTCCAGCAGCAACTCCCAGCCGTGG 









D.1 Materials and Methods 
D.1.1 Influence of pH and temperature on enzyme activity 
Initial specific activity measurements were conducted on a DU 800 spectrophotometer 
(Beckman Coulter; Brea, CA). Oxidation of the cofactor NADH was monitored at 370 
nm (  = 2,660 M-1.cm-1).176 Enzyme pH activity profiles were obtained at 25 °C with 
0.1 µM enzyme, 0.5 mM NADH, and 0.1 mM 2,4-DNT. 100 mM buffers containing one 
of the following salts: sodium citrate (pH 4-6.5), NaPi buffer (pH 6-8), Tris-Cl (pH 7-9) 
and glycine (pH 9-10). 
The dependence of the enzymatic activity on temperature was studied with 100 
mM NaPi buffer (pH 7), 0.1 µM enzyme, 0.5 mM NADH, and 0.1 mM 2, 4-DNT. The 
buffer was equilibrated to the target temperature and the enzyme was added. After 1 min 
of incubation, the assay was initiated with addition of the substate. Measurements were 
conducted over a temperature range of 10 to 55 °C. 
D.1.2 Circular dichroism (CD) 
Since the imidazole which is added during the purification has a high absorbance at the 
used wavelength spectra is was removed by size exclusion chromatography (PD-10 
Desalting Column, GE Healthcare). The ellipticity was measured with a Jasco J-810 
circular dichroism (CD) spectrophotometer (Easton, MD) equipped with a Peltier 
temperature controller. The temperature was increased at a rate of 1 °C min-1 with a range 
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of 10-90 °C at 220 nm. The protein concentration was 0.675 mg.mL-1 in 10 mM NaPi 
buffer (pH 7).  
D.2 Results and Discussion 
D.2.1 Characterization of NRmycsm 
Characterization of NRmycsm according to its activity dependence on pH and 
temperature were determined. The highest activity is achieved at pH 7 with phosphate 
buffer.  
 
Figure D.1 NRmycsm activity profile a) in different buffers (100 mM) at different pH 
values at 25 °C and b) at various temperatures with 50 mM NaPi buffer (pH 7.0). 
 
The pH-activity curve shows an activity maximum of 14.4 U.mg-1 at pH 6.5 with citrate 
buffer and of 13.9 U.mg-1 at pH 7 with phosphate buffer. The activity with Tris-Cl and 
TEA-Cl was significantly lower at similar pH values compared to phosphate buffer, 
which indicates that the activity is also buffer dependent (Figure D.1a). This was 
different from other nitroreductases like NRsalty from Salmonella typhimurium which 
showed higher activity with Tris-Cl than in phosphate buffer. However, the pH-optimum 
of NRmycsm is similar to NRsalty.39  




















































 The temperature-activity curve shows a temperature optimum at 30 °C where the 
specific activity is 25.6 U.mg-1. Interestingly the activity of NfnB decreases only by 18.9 % 
to 20.7 U.mg-1 at 10 °C compared to 30 °C (Figure D.1b). Using an Arrhenius relation 
for the temperature range from 10 to 30 °C gives an activation energy, EA, of 22.6 J.mol-1. 
The relatively low activation energy and the low temperature optimum might be the 
reason for better expression at room temperature compared to 37 °C. The unusual 
phenomena of low activation energy and temperature optimum was recently descript for a 
Nitroreductase from Staphylococcus saprophyticus.31 
D.2.2 Thermal stability of NRmycsm 
 
Figure D.2 Thermal denaturation of NRmycsm in 10 mM NaPi (pH 7.0) 
 
The melting temperature (Tm) of proteins can be determined by measuring the change in 
ellipticity as a function of temperature. When heated the protein denatures and loses its 
ordered structure such as α-helices and β-sheets. The loss of ordered structure contributes 
to the change in ellipticity. The normalized ellipticity as a function of temperature reveals 





















a single stage unfolding of NfnB and the melting temperature can be calculated from the 










Table E.1 Growth conditions for KYE variants 
Variant Temperature (°C) IPTG (mM) 
WT 37 0.5 
T37G 37 0.5 
M39Y 18 0.5 
W116A 18 0.1 
W116Y 30 0.5 
H191A 30 0.5 
N194A 30 0.5 
F296A 37 0.1 
Y375A 37 0.1 
T37G/Y375A 37 0.5 
M39Y/Y375A 30 0.5 
F296A/Y375A 18 0.5 
W116Y/Y375A 30 0.5 
T37G/M39Y/Y375A 30 0.5 
T37G/W116Y/Y375A 18 0.5 
T37G/H191A/Y375A 37 0.5 
M39Y/H191A/Y375A 18 0.5 
M39Y/N194A/Y375A 18 0.5 
H191A/F296A/Y375A 30 0.5 
N194A/F296A/Y375A 18 0.5 
H191A/N194A/F296A/Y375A 18 1.0 











Table E.2 Summary of KYE1 variants activity comparison  
Enzyme ER (U.mg-1) NR (U.mg-1) NR/ER ratio
WT 2.27 0.01 0.00 
T37G - 0.13 - 
M39Y 1.97 0.08 0.003 
H191A N.D. 0.12 1.49 
N194A 1.26 0.42 0.14 
W116A N.D. 0.00 0.00 
W116Y 0.39 0.25 0.17 
F296A 1.33 0.23 0.04 
Y375A 0.09 0.31 1.12 
T37G/Y375A N.D. N.D. 0.00 
M39Y/Y375A 0.37 0.74 1.49 
W116Y/Y375A N.D. 0.63 39.6 
F296A/Y375A 0.12 1.12 10.3 
H191A/N194A N.D. 0.74 54.6 
T37G/M39Y/Y375A 0.40 0.07 0.01 
T37G/W116Y/Y375A 0.03 0.07 0.14 
M39Y/H191A/Y375A N.D. 0.26 6.79 
M39Y/N194A/Y375A N.D. N.D. - 
H191A/F296A/Y375A N.D. 1.03 106 
N194A/F296A/Y375A 0.47 0.68 0.98 

















Figure E.1 Enzymatic production of 4-HABS from 4-NBS. 1 mM 4-NBS with glucose 
dehydrogenase (GDH) recycling system (2.4 U.mL-1 GDH, 0.1 mM NADP+, 10 mM 
dextrose) at 25 °C. 
  









COLORIMETRIC ASSAY METHODS 
 
F.1 MBTH assay 
F.1.1 Chemicals 
3-Methyl-2-benzothiazolinone hydrazone hydrochloride monohydrate (MBTH) and 
ammonium cerium(IV) sulfate dehydrate (ACS) were purchased from Sigma-Aldrich (St. 
Louis, MO) 
F.1.2 Color development 
Experimental procedures were developed based on previously published 
methods.235,240,241 Stock solutions of 0.1% (w/v) MBTH was prepared in water (4.28 mM 
) and 0.2% (w/v) ACS was dissolved in acidified water (0.4% (v/v) sulfuric acid in water) 
(3.16 mM). Substrates were initially dissolved in DMSO (1 M) then diluted 4 mM in 250 
μL of water. To this solution, 250 μL of the MBTH and ACS stock solutions were added. 
This was incubated over 10 mins and the spectra were recorded using a DU 800 
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